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ABSTRACT

HOST RESPONSES TO THE PHENOLIC-GLYCOLIPID-1 ANTIGEN OF
MYCOBACTERIUM LEPRAE

by
Richard W. Truman

Antibody responses to the apparently species specific
phenolic-glycolipid-1

(Phen-Gl-1)

antigen of Mycobacterium

leprae were examined in humans and armadillos using enzymelinked immunosorbent assays

(ELISA).

Statistical

definitions for the interpretation of positive and negative
reactions were derived,

a

retrospective serological survey

of armadillos indicated that leprosy in the wild armadillo
is a naturally acquired zoonosis.

Presently 12.5% of the

armadillos in 2 parishes in south central Louisiana have
detectable IgM antibodies to Phen-Gl-1.

Approximately 2.7%

of these histologically exhibit clinical disease.
Antibodies were not detected in Florida armadillo sera.
Variations in prevalence rates were noted, and may be due
to environmental conditions,

population characteristics or

some intricacies in the transmission of leprosy.

Naturally

acquired leprosy in the armadillo may be used as a model to
study transmission and baseline data have been derived.
The ELISA was shown to have application in the management
of experimental leprosy infections in armadillos.
Resistant armadillos were noted to have an irregular or

absent antibody response to the Phen-Gl-1 antigen over the
course of an experimental infection.

Armadillos infected

in the wild also had an irregular IgM response.
Susceptible armadillos appeared to have a long-term IgM
antibody response to Phen-Gl-1 becoming detectable some 186
days post-experimental infection.

This antibody remained

detectable for up to 1140 days post-infection.

Antibody

responses of susceptible armadillos correlated with the
harvestable load of M. leprae in liver tissues and ELISA
absorbances successfully predicted a harvest result 97% of
the time.

IgM antibodies to Phen-Gl-1 were earlier and

more reliable than other indicators of infection previously
applied.

IgM, IgA, and IgG antibodies to Phen-Gl-1 were

detected in leprosy patients and contacts.
be the predominate isotype detectable.

IgM appeared to

Human patients

showed no significant correlation of antibody relative
their clinical status.

IgM antibodies to Phen-Gl-1 were

depressed as a result of therapy with thalidomide.
Monitoring Phen-Gl-1 antibodies in human patients is not
predictive of patient status or reaction and does not seem
indicated for clinical management.

x

CHAPTER 1; INTRODUCTION

Leprosy is a disease of certain antiquity yet infects
approximately 11 million people in the world today (173)^
Caused by Mycobacterium l e prae, the disease progresses
slowly in man and can result in severe deformation,
debilitation, and death.

Patients present a complex

spectrum of clinical and immunologic symptoms

(27,85)#

They are plagued by a number of acute reactional states and
management of the leprosy patient is complex.

Early

diagnosis of leprosy is helpful in avoiding pain and
suffering, and techniques to aid diagnosis and management
are greatly needed (58) p
Serology holds hope for use in the early diagnosis of
leprosy and may prove useful in the management of leprosy
patients.

However, the serology of M. leprae has been most

complicated.

Previous serologic techniques used undefined

antigen mixtures and lacked both sensitivity and
specificity (130)_

Recently a phenolic glycolipid antigen

of M. leprae was isolated.
(Phen-Gl-1)

The phenolic-glycolipid-1

antigen is chemically defined and apparently

species specific for M. leprae (22,33,78)#
specificity of this antigen may alleviate many problems
previously encountered in leprosy serology.
The purpose of these investigations was to provide
basic information about the antibody response to the
phenolic-glycolipid-1 antigen and to develop it further for
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use in leprosy.
development,

The following chapters describe the

evaluation and application of enzyme-linked

immunosorbent assays
humans.

(ELISA) for use in armadillos and

The applications include epidemiology and

prospective management.

CHAPTER 2; REVIEW OF LITERATURE

Leprosy

(Hansen's disease (HD); hanseniasis)

is a

chronic mycobacterial disease primarily affecting the
peripheral nervous system and secondarily involving skin
and other tissues.

Generally a disease of the Third World,

training in leprosy is usually neglected in developed
countries

(58) _

fj0

the reader's understanding, a brief

review has been prepared.

Characteristics of the M. leprae

organism, transmission, classification, epidemiology and
immunology of leprosy are discussed in general.

Emphasis

has been given to serologic events in leprosy and the assay
systems used to detect them.

The o r g a n i s m ;
Mycobacterium leprae was first described by
Armauer Hansen in 1873

(59) ^

iphe organism is an acid fast

bacillus of apparently high infectivity but low
pathogenicity (84) ^

Although there are occasional reports

to the contrary, a general consensus holds that M. leprae
has not been cultivated on artificial media and researchers
must rely on iri vivo propagation methods as a source of M.
leprae.

The mouse footpad, the nine banded armadillo

(Dasypus n o v e mcinctus), the mangabey monkey and a variety
of immunodeficient animals have been shown to support
growth of M. l e p r a e .
leprae

Shepard first reported growth of M.

(from nasal washings)

in the mouse footpad in 1960
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(178).

The mouse supports limited replication and the

infection does not disseminate.

This model is currently-

used for drug sensitivity evaluations,
experimental vaccines.

and evaluation of

Growth of M. leprae in the

armadillo was first reported by Kirchheimer and Storrs in
1971 (97).

The armadillo uniquely sustains a disseminated

infection and is in common use for the production of large
quantities of M. l e p r a e .

Infection in the mangabey monkey

has only recently been reported and, along with the
armadillo, may develop as another animal model to study the
host-parasite relationship in leprosy (117).
Identification of M. leprae is presumptively made on the
basis of an acid fast bacillus whose acid fastness is
pyridine extractable (115)
DOPA

(144,145).

and has the ability to oxidize

More specific methods for identification,

including antigenic analysis and DNA hybridization, are
developing (8>,

Confirmation is usually dependent on a

histological examination which requires presentation of a
typical leprosy profile with acid-fast bacilli in
peripheral nerves (86).

m

. leprae has no flagella or

observable appendages, and appears to be nonmotile

(143).

Antigenically, M. leprae are similar to organisms of
the MAIS complex

(M. a v i u m , M. intracellulare, M.

scrofulaceum) (12).

They bear a number of antigens which

cross react with these and other mycobacterial species.
Using sera from lepromatous patients or antisera raised in
rabbits, serological cross reactions have been noted with
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M. a v i u m , M. g a l l inarum, M. s i m i a e , M. c h i t a e , (103) m .
s meg m a t i s , M. k a n s a s i i , M. p h l e i , M. fortuitum, M. balnei
(133) an(j m . bovis

(BCG)

(63) ^

using lymphocyte blast

transformation in humans, mice and rabbits sensitized with
l ep r a e ; M. bovis

(BCG), M. duvallii

nonchromoqenicum and M. vaccae

(54)

g i l u u m , M.

(189) were shown to

cross

react with M. l e p r a e .
Skin test cross reactivities and monoclonal antibodies
have added M. gordonae to the list (50,81)_

while the

antigenic determinants responsible for cross reactions may
not be major antigenic complexes of M. l e p r a e , even minor
complexes in mycobacteria can promote strong cross
reactions.

This phenomenon has been coined "Original

Mycobacterial Sin"

(4).

The cross reactivity of M. leprae

with other mycobacterial species has complicated
vaccination trials and attempts to monitor M. lepraespecific immune responses

(H).

A number of investigators have sought to identify
antigenic determinants that are specific for M. l e p r a e .
The first refinement of

M. leprae antigen systems was the

so-called antigen 7 by Harboe (65,135)#

This mixture of

antigens was identified by gel diffusion studies with
lepromatous sera on sonicated fractions of whole M. l e prae.
The majority of lepromatous patients examined had
antibodies that precipitated this antigen.

While

recognized as a mixture of determinants, some sought to
enhance the specificity of this antigen by absorbing test
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sera with a variety of other mycobacterial species

(e.g.,

BCG, M. a v i u m , and M. nonchromogenicum) (61,67)#
Absorption to promote specificity did not meet the criteria
for a species-specific antigen (61).
Gillis

(

Recently, Ivanyi and

r i n d e p e n d e n t l y reported a monoclonal antibody

that reacts with a specific antigenic determinant on M.
leprae.

The epitope with which this antibody reacts is

believed to be protein, but the determinant has not been
defined

(81,50).

Brennan

(Colorado State University)

has identified a

specific antigen in the lipid fraction of M. l e p r a e .

A

phenolic glycolipid in nature, its specificity is imparted
in a trisaccharide terminus of:

3-0-Me-rhamnose;

2 , 3-d-O-Me-rhamnose and 3, 6-d-O-Me-glucose glycosidically
linked to the phenol substituent (21,77) ^

qihe

immunodominant portion of the molecule appears to be the
terminal glucose residue (25) ^

rphe xipid structure is

related to mycoside-A of M. kansasii and is similar to
other oligosaccharides found on mycobacteria of the MAIS
complex

(78)#

Serological cross reactivities have not been

reported with other mycobacterial species.

As yet, little

is known of the immune response to this antigen.

Epidemiology:
The rate at which leprosy spreads depends on the
proportion of susceptible persons in the population and
their opportunity for contact with M. l e p r a e .

Adults are
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thought to be relatively insusceptible; most attempts to
infect volunteers have failed and conjugal leprosy is only
about 5%.

Children seem most susceptible.

When there is

leprosy in a family, up to 100% of the children may develop
the disease (68) <

^he incubation period for leprosy is

thought to be 3 to 5 years.

Shorter and longer periods of

incubation have been reported.

Although the bacilli do not

cross the placenta, bacillary antigens do.

The effect of

these antigens on eventual susceptibility is uncertain.
Leprosy has world distribution, but is highest in tropical
and sub-tropical climates.

It is found less commonly in

the Mediterranean population, Australian aborigines, and
natives of Texas and Louisiana (58).

Transmission;
Transmission of leprosy may be direct or indirect, but
direct contact may be more effective.

Long-term close

contact seems to be required for the establishment of
infection.

The exact site and mode of entry of M. leprae

into the host has not been established.

The organism

probably enters the body as any other pathogen, either
through the skin, the respiratory tract, or the
gastrointestinal tract.

Broken epithelium may be necessary

for entry through the skin.

Large numbers of organisms are

shed in the nasal secretions of a leprosy patient with high
bacillary load, which may imply a respiratory mode of
transmission

(84) ^

outcome of infection may be
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determined by the organism's route of entry,

the size of

the inoculum and the resulting host-parasite interaction.
The route of entry could determine how the organism is
presented to the immune system (193)p

The inoculum size to

which the potential host is exposed (either a single event
or chronically over time) could also influence the response
of the host immune system.
Environmental factors influencing transmission of
leprosy have been described.

High relative humidity and

warm temperatures correlate with increased prevalence rates
of leprosy (80)#

Kazda recently isolated a M. leprae-like

organism from a sphagnum bog in Norway.

The organism is

DOPA and pyridine positive, and reportedly bears the
phenolic glycolipid-1 antigen (92,25)#

The role of the

environment or environmental microorganisms as

pathogens

or additional factors influencing the transmission of
leprosy has not been described.

Stanford speculated that

environmental mycobacteria antigenically similar to
M. leprae may contribute to susceptibility for leprosy
(190).

Antibodies elicted from previous exposure to

environmental mycobacteria may mask epitopes important in
the cell-mediated recognition of M. leprae ( H ^ .
The clinical form of disease presented by a given
individual may be dependent upon the route of entry or host
factors such as genetic makeup, nutrition and active
infections or therapy which may play a part in reduced host
resistance (84) _

j n recent years,

there has been evidence
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that the immunological

status of the host may be

the most

important factor.

The clinical spectrum seen in leprosy is

closely related to

the status of the cell-mediated immunity

(CMI) of the host.

M. leprae are not eliminated

from the

body by humoral immunity (antibody) but are controlled or
eliminated by the CMI

(200).

Cl a s s i f i c a t i o n :
Disease classification schemes in leprosy must take
into account the clinical spectrum of the disease,

the

bacterial load, the histopathological appearance of the
lesions and/or the immunological status of the patient
.

one the most widely used classification systems is

the five-group Ridley-Jopling classification scheme

(153).

This system classifies leprosy patients based on
histopathologic features and the response to a lepromin
test.
The lepromin test consists of intradermal injection of
a phenol-treated suspension of heat-killed organisms
harvested from tissue of a high bacillary load (102).
Three types of responses have been described (149).
Medina reaction, which peaks at 4 to 6 hours, measures
antibody; the Fernandez reaction detects the presence of
competent T lymphocytes with a positive reaction at 48 to
72 hours as a delayed-type hypersensitivity reaction;
the Mitsuda (or lepromin)

reaction is noted grossly or

histologically at the injection site 2 to 3 weeks post
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inoculation.
granuloma)

A positive Mitsuda (well-defined tuberculoid

indicates that a person has the capacity to

develop competent cell mediated immunity for M. l e p r a e .
Across the Ridley-Jopling scale there are five
classifications of leprosy, ranging from polar tuberculoid
(TT) to polar lepromatous leprosy (LL).

Tuberculoid

leprosy is associated with a positive Fernandez
reaction.

(lepromin)

Patients of this class have competent CMI but

little circulating antibody is found (30).

Clinically,

there are few discrete asymmetrical lesions, typically
large and erythematous or hypopigmented with a dry
sometimes scaly surface.
defined and elevated.

The outer border is sharply

The inner border is vague and slopes

down to a flat, atropic center which exhibits anhidrosis
anesthesia, and a lack of hair growth.

Peripheral nerves

in the region of the lesion may be thickened and palpable.
Early manifestations of this form of leprosy may be sensory
loss followed by motor loss possibly leading to deformities.
Histologically, tuberculoid lesions are well-defined
granulomas with a central area of mature epithelioid cells
surrounded by a large lymphocytic infiltrate. The granuloma
must extend to the epidermis.

L a n g h a n s 1 giant cells may or

may not be present and acid-fast stains seldom reveal
organisms.

Since the granulomas follow nerves,

they are

often elongated and organisms may be found in involved
nerves

(85,153).
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On the opposite end of the spectrum is the patient
with lepromatous leprosy.

Lepromatous leprosy is

characterized by negative Fernandez and negative Mitsuda
reactions.

These patients have a nonfunctional CMI for M.

leprae and large quantities of antibody may be found.

The

hypergammaglobulinemia seen in these patients includes
heightened antibody response to many antigens, some
probably related to M. leprae and varying amounts of
autoantibodies

(30,113)^

Clinically,

these patients have

many diffuse and symmetrical lesions which may be macular,
papular or nodular.

Papules and nodules tend to be of

normal skin color, but macules are usually hypopigmented
and have vague indistinct edges with a shiny surface.
Nerves are infected but not thickened in early lepromatous
leprosy.
sensation.

Eventually there is hair loss and impaired
Lesions may become infiltrated to distinct

visibility and can progress to give characteristic leonine
faces and madarosis seen in late lepromatous leprosy.
Histologically,

in lepromatous leprosy the epidermis is

flattened and there is a clear zone separating the
epidermis from the diffuse granulomatous infiltrate.

The

granuloma is composed primarily of macrophages with
abundant vacuolated cytoplasm.

These foamy macrophages are

called lepra cells or Virchow cells.

On acid-fast

staining, many organisms are found inside these macrophages.
Lymphocytes and plasma cells may be scattered in the
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diffuse granuloma.

Lymph nodes are often extensively

involved (85,153)>
Between the two extreme poles of leprosy, there are
gradations of the disease with the midpoint designated as
mid-borderline (BB) or dimorphous leprosy.

Clinically,

there are a number of lesions which are anesthetic at the
center but have well-defined inner borders and less
distinct outer edges.

Histologically there is a mixed

infiltrate showing both histiocytes and epithelioid cells
as well as numerous lymphocytes

(85,153)e

Between borderline and tuberculoid,

those borderline

patients showing predominately tuberculoid features (but
too disseminated to classify as TT) are termed
borderline-tuberculoid

(BT).

The lesions are smaller and

more numerous, and satellite lesions may be present.

The

edges of these lesions are less well defined than those in
polar tuberculoid.

Histologically, BT granulomas consist

of epithelioid cells and lymphocytes forming a band in the
dermis separated from the upper dermis by a clear
area (85,153) .
The borderline lepromatous

(BL) patient shows more of

the features of lepromatous leprosy.

Their plaquish

lesions have an inverted saucer appearance with a sloping
outer margin, a steep inner margin, and patchy anesthesia
over some of the lesions.

The histology of a BL lesion is

that of focal collections of inflammatory cells macrophages, lymphocytes, and epithelioid cells.

Acid-fast
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staining will reveal many bacilli within the
macrophage (85,153),
Indeterminant (I) leprosy is considered the earliest
clinical manifestation of the disease.

There is usually a

single macular lesion which is usually hypopigmented and
rarely erythematous with indefinite edges.

The histology

of this lesion is nonspecific, having collections of
mononuclear cells around skin adnexa,
nerves

especially dermal

(85153),

Classification of leprosy is important for prognostic
as well as treatment purposes.

Classification is most

accurate when based on histopathologic as well as clinical
evaluation.

In 19 82, Job and Chacko modified the

Ripley-Jopling classification scheme to include a purely
neural form described earlier by Dharmendra and to
designate the mid-borderline

(BB) condition as so uncommon

and unstable as to represent a crossover point rather than
a group in the classification (85),

Treatment;
Present treatment recommendations for leprosy are a
combined regimen of dapsone,

rifampin and clofazimine in

patients with multibacillary disease and dapsone plus
rifampin in patients with few bacilli or lesions

(179),
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General leprosy i m m u nology;
The lack of an antibody response in tuberculoid
leprosy and the lack of a cell-mediated response in
lepromatous leprosy has been termed split anergy.

The

split anergy of leprosy is an interesting immunological
phenomenon and the mechanism of this anergy has been widely
debated.

Some have suggested that the defect of cell-

mediated immunity in lepromatous leprosy is generalized or
nonspecific (28,212 ) f while most feel the impairment is
specific to M. leprae (18,38,52 1 5 1 , 2 1 3 ) (
Lepromatous patients are capable of mounting a high
level of cellular resistance to other intracellular
parasites

(e.g., Leishmania b r a z i l i e n s i s ) (38)r and an

increased incidence of other infections and tumors in
leprosy patients is not seen (200)^

gtoner has suggested

that leakage of bacilli into circulation at an early stage
of infection might preferentially stimulate the central
lymphon compartment while circumventing the peripheral
lymphon compartment.

He suggested that there is a

subsequent development of suppressor cells rather than
normal activation of the effector cells essential to
establish CMI

(193)t

Cell-mediated immunity relies on the interaction of
macrophages, T lymphocytes, and possibly natural killer
cells

(207)#

The split anergy of leprosy may be the result

of some dysfunction in the communication of these cells.
M. leprae-induced impairment of the lymphocyte/macrophage
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interaction has been reported in patients with lepromatous
leprosy (55),

convit showed that macrophages of

lepromatous patients could eliminate M. leprae when
properly stimulated (39),

such proper stimulation required

a population of sensitized lymphocytes.
lymphocytes,

Absence of these

either functionally or physically,

could

account for the inability of lepromatous patients to
respond adequately to M. leprae antigens

(53),

Considering the granulomas of leprosy, rhinoscleroma,
and sarcoidosis, Modlin used monoclonal antibody to
demonstrate two different patterns

(121,122),

Granulomas

of tuberculoid leprosy and sarcoidosis had T helper cells
thoughout the granuloma with T suppressor cells in the
mantle of the lymphocytes surrounding the well-formed
granuloma.

Both helper and suppressor cells were diffusely

scattered throughout the loose granulomas of lepromatous
leprosy and rhinoscleroma.

No surrounding mantle of T

suppressor cells was present.

It was postulated that the

close association of T helpers and epithelioid macrophages
in well-formed granulomas may reflect active cooperation to
promote an effective immune response.

The surrounding T

suppressors m a y serve to contain the granulomatous reaction.
The haphazard arrangement seen in the diffuse granulomas of
lepromatous leprosy might reflect a relative inefficient
host response that allows M. leprae proliferation.

Van

Voorhis has reported that T suppressor cells are scattered
throughout the diffuse granulomas of lepromatous leprosy,
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and that T helper cells were present in the well-organized
granulomas of tuberculoid leprosy (206),

<r suppressor

cells from lepromatous patients also failed to suppress
normal B cell responses to the pokeweed mitogen, and B
lymphocytes of lepromatous patients showed a higher mitogen
response than normal controls or patients with tuberculoid
leprosy (26,31),
While there is much evidence to indicate a T cell
defect in lepromatous leprosy, splenic entrapment and
inhibition of recirculation of lymphocytes might prevent
their response to antigenic stimuli.

Splenic entrapment of

lymphocytes has been reported in the murine leprosy model
(26),

Two stages of splenic suppressor activity were also

demonstrated in that model: early suppression was mediated
by macrophages and late suppression was by T lymphocytes.
Thus, the specificity and mechanism of the split anergy of
leprosy is not well understood, but leprosy patients are
markedly different from normal individuals and show great
heterogeneity among themselves

(26),

Reactions:
Leprosy patients also suffer a number of severe
immunological reactions.

An important focus of the

immunology of leprosy is to develop methods that would aid
in the management of these reactions.

The reactional

states of leprosy are broadly placed into two categories:
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type I lepra or reversal reactions,

and type II lepra or

erythema nodosum leprosum.
Reversal reactions

(type I lepra) occur in patients in

the nonpolar and polar extremes of the leprosy spectrum.
These reactions are brought about by a change in the CMI of
a patient

(68,70,88).

They are by nature type IV

hypersensitivity reactions according to the Gell and
Coombs'

scale

(41).

Clinically, patients exhibit increased

erythema and edema in existing skin lessions and swelling
of nerves

(37).

classification;

Histologically,

there is a shift in

treated patients undergoing reversal, by

definition move toward tuberculoid and have increased
lymphocytes in their granulomas with a decrease in the
number of viable (solid-staining)
bacilli

and total acid-fast

(68,70,88).

Also grouped with the type I lepra reactions is the
so-called "downgrading" reaction of the borderline leprosy
patient

(68,70,88).

clinical features here are similar to

those for the reversal reaction and manifest as a delayedtype hypersensitivity

(158,159).

However, these patients

are moving toward the lepromatous end of the spectrum.
T h e Akuter-Schub (acute panic)

reaction is rare and

occurs in the borderline lepromatous patient who is
downgraded to lepromatous.

With treatment, the patient has

a slow upgrading until at some point the CMI is activated
and the patient experiences multiple reversal reactions at
sites where there is residual bacteria.

This is a serious
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reaction, and results in multiple skin lesions and nerve
involvement (68,70,88)^
Drugs used in suppression of reversal reactions are
steroids and clofazimine (68,70)^
Type II lepra reactions occur in the lepromatous
spectrum of leprosy.

They are manifest in a rare event

known as Lucio phenomenon or in the more common reaction
erythema nodosum leprosum (ENL)..

Lucio occurs only rarely

and only in a specific sub-type of lepromatous leprosy,
predominately in patients in Sinalou, Mexico.

It is a

severe complication of lepromatous leprosy characterized
clinically by crops of irregular, stellate infarctions of
the skin without nodular lesions

(37)t

These infarctions

result in necrotic, ulcerated lesions which are sharply
separated from the surrounding non-inflammed skin, and
sloughing occurs.

Lucio acts as a severe vasculitis of

deep dermal vessels with thrombosis effectively cutting off
blood supply leading to deep ulceration (68)#
Erythema nodosum leprosum (ENL) or type II lepra
reaction is the most common complication of lepromatous
leprosy and accounts for the majority of permanent sequelae
in this disease type.

Approximately 50% of lepromatous

leprosy patients will experience ENL some time during the
course of their disease.

Although ENL usually occurs by

the end of the first year of sulfone therapy,
manifest in the untreated patient.

it may also

Therefore, ENL is

considered a manifestation of the disease rather than a
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complication of therapy (150).

ejjl

can be triggered by

intercurrent infections, vaccinations, pregnancy and
physical or emotional stress

(17,68,70,88).

clinically,

ENL is characterized by crops of tender erythematous
papules or. nodules on grossly uninvolved skin
(37,68,70,88,149,200).

^he lesions are edematous and

evanescent, lasting only 24 to 48 hours before spontaneous
regression and may leave a faint bluish hyperpigmentation
with slight desquamation of the surface

(37,68 ,70,88)_

Eruption may be accompanied by general malaise, vague pains
and an elevation in temperature.

Lesions usually appear on

the face, trunk, and extremities with the extensor
surfaces of the limbs being favorite sites (68,70,87).
ENL exists in three phases
(described above)

(68,70,87). the acute phase

is often accompanied by systemic symptoms

of intermittent fever, polyarthralgia, polyneuritis, tender
lymphadenopathy, iridocyclitis, and orchitis.
resolves

in two to three weeks.

This phase

In the subacute phase of

ENL, crops of nodules recur at frequent intervals taking
two to three months to resolve.

In the chronic phase,

nodules m a y continue to erupt with attacks lasting for
several years.

The patient with ENL will have an elevated

sedimentation rate, a leukocytosis and proteinuria (37,212).
Glomerulonephritis can be a complication of severe ENL.
severe episodes of ENL, lesions may become hemorrhagic,
necrotic and ulcerated (68,70,87).

In
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ENL is viewed as a hypersensitivity reaction and
inf lamination in the episode is considered of an allergic
nature.

Since ENL often occurs in the lepromatous patient

during treatment, destruction of mycobacteria with a
probable release of M. leprae antigens m a y be indicated in
the pathogensis of the syndrome.

Analogies have been made

between ENL and the Jarisch-Herxheimer reaction frequently
encountered in the treatment of syphilis
Histologically,

(37) #

the lesions of ENL resemble those of the

Arthus phenomenon

with deposition of antigen-antibody

complexes in vessel walls with resulting complement
fixation eventuating in a leukocytoclastic vasculitis.

An

important characteristic of ENL is that there is no change
in leprosy classification during the course of the reaction
(68,70,212) f an<j there is no clinical evidence of extension
of the disease or new lepromatous lesions (37) #
Recommended treatment for ENL are steroids,
clofazimine, or thalidomide when not contraindicated
(15,68).

Pathogensis of E N L ;
Erythema nodosum leprosum occurs only on a substrate
of lepromatous leprosy (37,68,70)^

Patients with this form

of leprosy demonstrate the immunological dichotomy of a
split anergy having hypergammaglobulinemia with varying
degrees of depressed CMI

(170)#

*rhe pathogenic mechanism

for the initiation of ENL has not been described.

Proposed
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mechanisms for the initiation of ENL may be divided into
three broad categories:

immune complexes

(either tissue

complexes or circulating immune complexes) with activation
of classical complement pathways; activation of the
alternate pathway of complement without participation of
immunoglobulins;

or some perturbation in control mechanisms

at the cellular level

(68,148)>

Lepromatous leprosy patients carry a high bacillary
load which provides chronic antigen stimulation.

ENL is

often precipitated during treatment where the bacterial
index (BI) and morphological index (MI) drop as the patient
responds favorably to therapy.

Chronic antigen stimulation

in lepromatous patients provides a stimulus for continued
antibody production.

A cyclical production of antibody,

particularly IgM, may result from such persistent antigen
stimulation

(68,70,212)^

polyclonal immunoglobulinemia has

been observed in leprosy patients both with and without ENL.
New patients also tend to present with elevated
immunoglobulin levels.

IgM-type antibodies may decline

with treatment, while IgG- and IgA-type antibodies may
remain elevated

(30,68,70,170,216)#

Because the histological picture of ENL is so similar
to that of the Arthus phenomenon, it has long been
postulated that ENL is mediated by the deposition of
antigen/antibody complexes and subsequent activation of the
classical complement pathway.

ENL also has systemic

features very like that of serum sickness, suggesting the
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presence of circulating immune complexes

d 7 >.

An early

indication of immune complex formation was provided by the
demonstration of cryoglobulins in lepromatous patients
(113)4

Cryoglobulins were present in 97% of those without

ENL, 100% of those with untreated ENL, and 58% of those
with ENL on steroid therapy.

These cryoglobulins were

shown to be of a mixed type and anti-IgG activity was
demonstrated in the IgM component (18).

It was postulated

that autologous IgG may become autoantigenic following
reaction with a primary antigen.

This altered IgG may then

stimulate the host immune system to respond by producing a
corresponding IgM antibody.
anti-IgG -IgM)

These complexes

(IgG plus

could then be instrumental in the induction

of ENL (18).
Deposits of immunoglobulin and complement have been
demonstrated by immunofluoresence in the lesions of
approximately 55% of ENL patients

(212,214)^

d epO S its

were perivascular and located in areas corresponding to the
infiltration of polymorphonuclear neutrophils

(PMNs).

Soluble mycobacterial antigen was detected in some of these
complexes, which were sometimes located within the walls of
blood vessels.

It was suggested that the lesions of ENL

are caused by these complexes, either formed locally
(Arthus)

or present in the circulation.

Deposits of immunoglobulin alone have been
demonstrated in the skin of lepromatous
patients

(29,73,147)#

Specific, fine granular deposits of
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IgM have been detected at the dermal-epidermal junction(29)
and also in the dermal collagen and elastic fibers of
lepromatous patients (147)_

t WO

possibilities were

suggested for the etiology of these deposits:

tissue-bound

IgM may be specific antibody to mycobacterial antigens, or
anti-mycobacterial antibody may cross react with basement
membrane antigen.

More recently,

skin biopsies from

reactive nodular lesions were shown to contain IgG (100%)
as well as IgM (58%)
junction

<73)#

in deposits at the dermal-epidermal

it is still not known if these deposits are

specific antibodies to mycobacterial antigens or
autoantibodies.
Circulating immune complexes have been detected in the
sera of leprosy patients by Clq precipitation in
gel (122,160)^

presence of these complexes was shown to

correlate with the clinical condition; complexes were
present in 33-70% of the lepromatous patients without ENL,
76% of the lepromatous patients with active ENL, 20% of the
tuberculoid patients, and only 3% of normal controls.

It

was suggested that localized complexes might mediate the
ENL lesions

(Arthus), while circulating immune complexes

might be associated with the systemic symptoms of ENL.

Clq

precipitation and gel assays are not without controversy.
Tung and associates have demonstrated that Clq also reacts
with DNA and bacterial antigens - the results of such tests
for the detection of immune complexes should be interpreted
with caution in patients with infectious diseases <201),
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Clq binding assays do not give false-positive reactions
with organisms or DNA (104),

using these methods,

it has

been shown that circulating immune complexes exist in the
sera of 82% of leprosy patients with uncomplicated
lepromatous leprosy,

80% of lepromatous patients with ENL,

and 58% of tuberculoid patients

(16),

Differences also

exist between leprosy patients in endemic and nonendemic
areas

(205),

j n endemic areas, patients across the leprosy

spectrum can demonstrate circulating immune complexes.
Circulating immune complexes are not demonstrable in TT and
BT patients from non— ndemic areas.

Thus, circulating

immune complexes are probably neither specific for ENL nor
related specifically to leprosy.

Reliable interpretations

of immune complexes in leprosy patients will probably only
be available when examinations are made using antigens
specific for M. l e p r a e .
Using C3d levels as a measure of complement catabolism
evidence for increased complement activation in patients
with ENL has been reported (16,205),
were postulated:

two

sources of C3d

immune complexes or C3d fragments

diffusing from extravascular sites of immune complex
deposition and complement activation (16),

During ENL, C3d

levels were high but returned to normal once the clinical
signs of ENL had subsided (205),

Thus, it was suggested

that ENL lesions are mediated by complement and that
elevated C3d levels are highly specific for ENL.
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Londono (109)

found C3d deposits in vessel walls, but

was unable to demonstrate immunoglobulin and suggested that
the alternate pathway of complement played an important
role in ENL.

Other investigators have noted a fall in the

C3 level and an elevation in the Ba {breakdown product of
factor B) in ENL (168).

These workers proposed that during

the initial phase of acute ENL there is a sudden release of
M. leprae antigens into circulation which first initiates
the classical complement pathway and, subsequently,
alternate complement pathway.

the

Overall, there is little

agreement about the role of complement in the initiation of
ENL.
Mshana, et al.

(126) found mycobacterial antigen in

all biopsies from lepromatous patients

{with or without

E N L ) , while only 23% of ENL patients were positive for
immunoglobulin or complement deposits.

Both ENL and

lepromatous patients without ENL had foamy,macrophages
with large amounts of mycobacterial antigen.

In ENL, these

macrophages were said to rupture and release antigens into
the extracellular spaces.

Absence of immunoglobulin and C3

in the presence of extracellular antigen in ENL was taken
to indicate that mycobacterial antigen is more important
than antigen-antibody complexes for the initiation
of ENL (158,159).
The presence of large quantities of M. leprae antigens
provides chronic stimulation to the partially responsive
immune system of lepromatous patients.

Turk has suggested
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that the continued stimulation of these cells might induce
a population of B suppressor cells capable of modulating T
cells, as well as those that develop into conventional
antibody producing cells

(200),

Bach

(9) an<j Wallach (209)

used monoclonal antibodies to show that lepromatous
patients with recent ENL have a decreased number of T
suppressor cells in the peripheral blood and an increased
number of T helper cells.

In mixed lymphocyte cultures

these cells were noted to have an elevated response to
mitogen.

The helper/suppressor ratio was normal in both

tuberculoid patients and nonreactional lepromatous patients.'
It was postulated that the imbalance between T cell subsets
contributed to the occurrence of ENL in lepromatous
patients.

Later, Mshana (125)

showed an increase in T

suppressors and the peripheral blood of lepromatous leprosy
patients and a transient acute inversion of the
helper/suppressor ratio during ENL.

The transient decrease

in T suppressors could be due either to decreased
production of T suppressors or to increased sequestration
of those cells in tissues

(161),

The mechanism by which

these cells may affect regulation in ENL is as yet unknown.
However, other cell types seem to be affected during ENL.
Cytotoxic T cells have been shown to be defective in
lepromatous patients without ENL and to become functional
in patients during ENL

(189).

This deficiency could be

either part of a reactional process or part of the
underlying T cell abnormality of lepromatous leprosy.
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Humphres,

et al.

(76) has described depressed natural

killer (NK) cell activity in ENL patients, and the
patients'

own monocytes were seen to be responsible for the

depression of NK activity.
The various theories as to the induction of ENL are
not mutually exclusive, and a number of mechanisms may
interact.

Regardless of the exact sequence of events and

whether ENL is cellular or immune-complex initiated,

the

common denominator is the presence of PMNs in ENL lesions.
It is obvious that this is the cell that directly mediates
the tissue damage.

What is not known is the mechanism by

which PMNs are recruited.
Thalidomide has been shown to be effective in the
treatment of ENL.

Understanding the mechanism of action of

thalidomide in halting the immunological and/or
inflammatory events in ENL might lead to a better
understanding of the immunopathology of ENL reactions.
Thalidomide has been shown to prevent PMN chemotaxis
(13,69)f to stabilize lysozomal membranes, and to
antagonize certain chemical mediators of inflammation
(histamine, serotonin, acetylcholine, and prostaglandin E-2
and F-2 alpha)

(71),

Therapeutic doses of thalidomide

decrease the generation of toxic oxygen intermediates by
PMNs

(120)#

Shannon

(176) demonstrated a selective

decrease in IgM in leprosy patients during treatment of ENL
with thalidomide, as well as an inhibition of de novo IgM
synthesis in mice.

It was proposed that IgM antibody is
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the relevant immunoglobulin-initiating immune complex
formation in ENL.

Recent studies using the T-independent

antigen DNP-Ficoll suggest that thalidomide either has no
effect or slightly augments the IgM antibody response to
this antigen.

Therefore, thalidomide appears to

selectively suppress the IgM response to T-dependent
antigens

(175).

IgM is primarily intravascular

(80%) and

the maximum complement fixing ability of IgM and soluble
antigen/antibody complexes is formed when the antibody is
in excess.

Therefore, favorable conditions for a type III

hypersensitivity reaction with IgM and complement fixation
occur intravascularly.

Complex formation at the vascular

epithelium can first occur as antigen diffuses from tissue
spaces

(32)^

initial vascular damage occurs

permeability increases, allowing penetration of IgM into
the vessel wall since mor e complexes may form as more
antigen is encountered.

Perhaps only when ENL is examined

in the light of antibodies, antigen and immune complexes
specific for antigens of M. leprae will the pathogenesis of
the reaction be understood.

Serology:
Resistance to leprosy is primarily dependent on the
cell-mediated immune system, but M. leprae does stimulate
an apparently nonprotective humoral response (1/203)#
Serology holds hope to aid the early diagnosis and
management of leprosy cases.

Antibody levels in leprosy
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patients have been reported to reflect the different
clinical forms of the disease (91) an(j to change with
alteration of the antigen load in chemotherapy (91,152,197)^
A good review of serological attempts in leprosy has been
prepared by Melsom (130)#

Generally,

complement fixation,

passive hemagglutination, double diffusion in gels,
indirect immunofluoresence (IFA), gel precipitation,
radioimmunoassay (RIA), and enzyme-linked immunosorbent
assays

(ELISA)

have been used to detect antibodies in

leprosy patients.
Complement fixation tests were introduced for the
diagnosis of several infectious diseases around 1900.
Eitner (46) showed that antigen preparations from human
lepromas could fix complement with sera from leprosy
patients.

Sera from lepromatous leprosy patients showed

high reactivity in the complement fixation tests, while
sera from tuberculoid patients showed poor or no reactivity
(46) _

Based upon these and similar findings using

different test systems for antibodies in sera from leprosy
patients, paucibacillary tuberculoid leprosy patients have
been classified as "poor antibody responders" and patients
with multibacillary lepromatous leprosy,
responders"

(26)^

"good antibody

This antibody response is also reflected

in increased immunoglobulin concentration (40) an£ j.n
increased frequency of autoantibodies,
factors, anti-thyroid antibodies,
antibodies

(149),

like rheumatoid

and anti-nuclear

Additionally, components from several
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mycobacterial and diphtheroid species could fix complement
with sera from leprosy patients

(40).

Therefore, the test

lacked specificity and only had use in diagnosis of
lepromatous leprosy (41,45)#
Mycobacterial antigen-antibody reactions were first
examined by hemagglutination tests in 19 48 (119)#
red blood cells
cells

sheep

{SRBC) were found to be the best carrier

^ 3 9 ) ^ and better results were obtained when SRBC

were sensitized with M. tuberculosis than with M.
leprae

L o w positive titers often resulted in sera

from normal controls.

Higher titers were noted in

tuberculoid leprosy patients, and the highest titers were
manifested by lepromatous leprosy patients

(106).

More

recently, there have been attempts to coat tanned SRBC with
M. leprae from armadillos.

Specificity was enhanced by

absorption of test sera with M. tuberculosis and M. v a c c a e .
Absorbed lepromatous sera still contained antibodies which
agglutinated the red. blood cells

(83) ^

However, these sera

also reacted with M. lepraemurium, M. b o v i s , M. p h l e b e s i n ,
M. g a s t r i , M. gordonae and M. nonchromogenicum by
immunodiffusion methods (162)^

jn some lepromatous leprosy

patients a decrease in titer was found in sera taken some
months after sulfone treatment was begun

(162)^

increase in titer could also be demonstrated when sera were
taken during an ENL reaction

(42).

The hemagglutination

test primarily confirmed the previous findings from the
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complement fixation test but also lacked specificity in its
determ inations.
The Rubino reaction was described in 1926 as a
sedimentation reaction between formalin-treated SRBC and
sera from leprosy patients.

Sera from patients with

diseases other than leprosy could not sediment such treated
SRBC (43,166)#

The Rubino test was mostly positive with

sera from lepromatous patients and negative with sera from
tuberculoid patients.
used in Latin America.

Until recently, the test has been
However, the Rubino reaction can be

inhibited by antigens from several mycobacterial species
and is positive during renal failure

(5,164)^

The test is

not specific for M. l e p r a e , and the value seems limited.
Gel precipitation methods were first applied using
lepromin and serum from lepromatous patients in 1957

(138)^

This technique, applied in double diffusion schema and
crossed Immunoelectrophoresis, has been used extensively in
the characterization of antigens of M. l e p r a e .

These

methods indicate that leprosy patients may respond
differently to a number of cross reactive antigens of M.
leprae.

Diffusion techniques are not suitable for

quantitation of antibody reactions, and the heterogeneity
of patient response m ake them unsuitable for the diagnosis
of leprosy and will not be discussed.
The indirect fluorescent antibody (IFA)

technique was

first used to demonstrate antibodies to M. leprae and M.
tuberculosis in 1961 (128)^

Leprosy patients had positive
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reactions with both M. leprae and M. tuberculosis.
technique was further developed by Abe

jjo

The

aid

specificity, Abe applied a series of absorbtions with
cardiolipin, lecithin, BCG, and M. v a c c a e .

After

absorbtion, diluted serum was applied to smears of M.
leprae obtained from leprosy patients or armadillos
To enhance reaction by removal of lipids and exposing
protein antigens, smears were treated with
carbon-tetrachloride and trypsin.

Reading was accomplished

with a special combination of fluorescent filters and based
on the amount of total fluorescence emitted by a single
organism.

Antibodies were detected in 100% of the

lepromatous leprosy patients and 80% of the tuberculoid
patients.

Antibodies were not detected in normal control

groups but were found in household contacts.

The IPA test

was also modified for use and presumptive identification of
M. leprae organisms

(114)^

Recently,

it has been shown

that sera absorbed by the scheme of Abe could also react
with M. lepraemurium, M. bovis, M. nonchromogenicum, M.
p h l e b e s i n , M. gordonae and M. gastri

<49)#

Therefore,

exposure to environmental mycobacteria and BCG may have
influence on the results of these studies.

IFA is not

specific for M. l e p r a e , and interpretations are subjective.
The test has not received wide application in other
l a bora t o r i e s .
Radioimmunoassay (RIA) has been used both
competitively and in solid-phase assays with antigen
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systems not specific for M. l e p r a e .

The first RIA in

leprosy used the antigen 60 from BCG.

Antibodies were

detected in 25 of 29 lepromatous patients and in 11 of 20
tuberculoid patients.

However, BCG vaccination is in wide

use and antibodies to this antigen would not be reliable
indicators of leprosy infection

(63).

using gel diffusion

to examine the sera of leprosy patients, Harboe noted a
specific line of precipitation more commonly formed by
reaction with fractions of sonicated whole M. l e p r a e .
Using this antigen 7 mixture in RIA, antibodies were
detected in 80% of the lepromatous patients and
occasionally detected in tuberculoid patients

(66).

Levels of antibodies in lepromatous patients were noted to
fall after the first year of dapsone therapy (135).
examining the sera from armadillos,

jn

antibodies to antigen 7

became detectable in experimental infections with M. leprae
only after establishment of the disseminated infection (49).
Owing to the mixture of antigens in the preparation,

it was

again necessary to absorb test sera with other
mycobacterial species to enhance specificity (64).
this time it is uncertain if the absorption scheme
adequately removes all cross reacting antibodies with M.
leprae.

The requirements for absorption may vary in

different populations depending on the mycobacterial flora
(130).

while the originial RIA was designed using

Staphlococcal protein-A as a precipitant of antibodies
reacting with iodinated fractions of whole M. l e p r a e , the
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assay has been modified for use in solid-phase analysis.
The solid-phase method allows distinction of antibody
isotypes

(127,128,129,130),

Antibody activities of

different patient sera varied widely.

IgM antibodies for

antigen 7 are highest in early lepromatous leprosy and
decline over term (134),

Antibodies were less often

detected in tuberculoid patients.

IgG and IgA antibodies

tend to decrease over term with sulfone therapy C133> _
Thus, IgM antibodies for antigen 7 are probably more
appropriate for early diagnosis of sub-clinical leprosy,
and other isotypes probably more responsibly indicate the
effect of therapy (132,134,135),

The preparation of

suitable amounts of M. leprae antigen 7 has been difficult
and different batches tend to yield different results

(126),

The requirements for absorption of sera also gives the
antigen questionable specificity, and assays using more
specific antigen preparations are needed

(60,61,99),

The phenolic-glycolipid-1 antigen is chemically
defined and readily available from the tissues of
experimentally infected armadillos

(21,77),

Although its

phthiocerol core is shared with M. k a n s a s i i , cross
reactions with the specific trisaccharide epitope have not
been described (33),

The nonaqueous nature of this antigen

originally complicated immunologic investigations.

To

demonstrate antigenicity in gel diffusion assays required
incorporation into liposomes

(22,141),

Although

complicating other aspects, this hydrophobicity especially
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recommends the antigen as an immunosorbent in solid-phase
assays.

Organic solvents and detergents were not useful in

dispersing phenolic-glycolipid-1 to solid phases.

They

either reacted with the sorbent material or would not
release the antigen for hydrophobic b i n d i n g - (78)#
Dispersing the antigen, either by deacylation of its lipid
side chains or sonication of the native lipid,

proved most

successful and today, a number of investigators have
developed ELISA assays

(44,107)^

this time, most

reports in the literature concern the specificity of the
antigen.

The specificity of the antigen lends well to

sero-epidemiologic studies, and there is hope that the
antigen may be used in the early serodiagnosis of leprosy
(20,24)'

phenolic-glycolipid-1 also offers a unique

opportunity to examine M. leprae-specific humoral responses
in leprosy patients.

The following studies use this

antigen as a mechanism to examine M. leprae-specific
humoral responses in leprosy patients and in armadillos for
both sero-epidemiology and management.

CHAPTER 3

DETECTION OF IgM CLASS ANTIBODIES
IN ARMADILLOS
TO THE PHENOLIC-GLYCOLIPID-1 ANTIGEN OF M. L E P R A E .
1. DEVELOPMENT OF A SEROLOGIC TEST

Richard W. T r u m a n l ' 2 r Edward J. Shannon2,

and

Robert C. Hastings^

^•Department of Veterinary Microbiology and Parasitology
School of Veterinary Medicine
Louisiana State University
Baton Rouge, Louisiana

^pharmacology Research Department
National Hansen's Disease Center
Carville, Louisiana
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Chapter 3: Abstract

An enzyme-linked immunosorbent assay (ELISA) using
antisera specific for human IgM and the phenolicglycolipid-1

(Phen-Gl-1) antigen of M. leprae has been

developed for immune status assessment of armadillos.
Human and armadillo IgM express sufficient serologic cross
reactivity to allow the use of commercially prepared
anti-human IgM to detect armadillo IgM antibodies.

Testing

plasma from 76 armadillos having a known experimental
inoculation history with M. leprae showed the assay to have
high sensitivity and specificity.

IgM anti-Phen-Gl-1

antibodies were detected both before and after the
appearance of acid-fast bacilli in peripheral blood,

buffy

coat cells of experimentally infected armadillos, and up to
36 months after the experimental infection.

Armadillos not

experimentally infected with M. leprae (4/20) also had
detectable IgM antibodies to Phen-Gl-l.

These antibodies

were absorbable with whole M. leprae, suggesting that wild
armadillos m a y have an antibody prevalence rate as high as
20%.

The assay has application for sero-epidemiology and

the monitoring of experimental infections with M. leprae in
a r m a di l l o s .
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The nine-banded armadillo (Dasypus novemcinctus) is
the most common host for the in vivo propagation of
Mycobacterium leprae (97) an(j
study of leprosy (194)>
generally unsuccessful,

an an imal model for the

Captive breeding of armadillos is
and animals must be taken from the

wild for use in scientific studies.

Wild armadillos have

been reported to harbor a mycobacterial infection that is
indistinguishable from M. leprae

(210) #

rp0 a v o ici

contamination of cultured strains and assure similarity of
immunological responses in model systems, recently captured
animals must be screened to assess their naivetd to M.
le p r a e .
Serology is a traditional means of screening animals
for infectious experiences, but the serology of M. leprae
has been most difficult.

M. leprae bears a number of

antigens which cross react with other mycobacterial species
(103,136)_

The insectivorous, burrowing armadillo

habitually encounters a wide variety of common soil
mycobacteria and likely develops antibodies to many cross
reacting antigens of M. l e p r a e .

previous serological

assays for M. leprae antibodies in armadillos have utilized
traditional Staphylococcal-A radioimmunoassay methodologies
with iodinated fractions of the sonicated whole leprosy
bacillus

(64,66)#

consequently,

they lacked both

specificity and the ability to distinguish antibody
isotypes

(179).

Recently, a chemically defined phenolic

glycolipid antigen (Phen-Gl-1)

of M. leprae has been
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isolated from the tissues of experimentally infected
armadillos.

The antigen has not been found in other

mycobacterial species and is apparently specific for M.
leprae (22,33,78)#

others have reported the development

and utilization of enzyme-linked immunosorbent assays
(ELISA) for antibodies to Phen-Gl-1 in human sera (24,78)^
We report here the development of an ELISA that detects
IgM-class antibodies in armadillo serum reacting with the
Phen-Gl-1 antigen of M. l e p r a e .

MATERIALS AND METHODS
Anti-armadillo s e r u m :

Rabbit anti-armadillo serum

globulins was a gift of Dr. T. E. Wilson, University of
Southeastern Louisiana
CIEP:

(Lafayette, Louisiana).

Crossed immunoelectrophoresis

(CIEP) was

performed by the method of Clark and Freeman (34)>

Serum

was electrophoresed in 1% agarose gel with 0.025 M tricine
buffer, pH 8.6, with constant voltage of 20 volts/cm
(BioRad 3000/300, Richmond,

CA).

Electrophoresis proceeded

for 50 min in the first dimension when a second slab was
cast that contained either second antibody conjugate or
anti-armadillo immunoglobulins.

Electrophoresis was

performed in the second dimension for 60 min before the
slabs were washed in normal saline and stained with
Coomassie blue to visualize antibody reactions.
Antigen:

Native purified phenolic glycolipid-1

(Phen-Gl-1) was prepared by Dr. Patrick Brennan

(Colorado
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State University)

and obtained through contract with the

National Institute of Allergy and Infectious Diseases

(Dr.

Darrel Gwinn, project Officer).
Experimentally infected control g r o u p ;

Armadillos

at the National Hansen's Disease Center are captured from
the wild and housed for the production of M. l e prae.

They

are periodically bled, both pre- and post-experimental
inoculation with M. l e p r a e , to examine for the presence of
acid-fast bacilli in peripheral blood, buffy coat cells.
Plasma from these bleedings is separated and stored at
- 8 0 °C for future use.
for this study.

Seventy-six such samples were used

Twenty of the samples were from animals

before inoculation with M. l e p r a e ; one of the 20 was from
an armadillo originally presenting from the wild with an
acid-fast bacterial infection that was indistinguishable
from that caused by M. leprae in that the bacilli oxidized
D-DOPA (144,145)

an(j their acid fastness was extracted with

pyridine ( H 5 ) .

The remaining 56 samples were from

armadillos that had been inoculated with M. leprae from 4
to 43 months before bleeding.

Thirty-one of the 76

armadillos had acid-fast bacteremia at the time of bleeding.
Two of these 76 sera were from animals that had resisted
challenge with M. l e p r a e , as shown by having no signs of
infection 28 months after inoculation with at least 1 x 10®
viable leprosy bacilli.
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ELISA;
ELISA-IqM vs. P h e n - G l - 1 ;

An enzyme-linked

immunosorbent assay (ELISA) was performed according to the
method of Voller and Bidwell
phenolic-glycolipid-1

(79).

Specifically, native

(Phen-Gl-1) was mixed with 0.05 M

carbonate buffer, pH 9.5, and suspended via sonication with
a 3 mm probe at 70 watts for 1 minute (Ultrasonics, Inc.,
Plainville, NY).

The suspended antigen was diluted in the

same buffer to a concentration of 2 jag in 50 jul the volume
which was added to each well of a 96 well polyvinyl flat
bottom microtiter plate (Cooke Labs, Alexandria, VA).

The

plates were sealed with Parafilm (American Can Co.,
Greenwich, CT) and incubated over night at 37 °C in a water
bath.

After incubation, the wells were washed 3 times for

5 minutes each wash with 200 jul of wash buffer consisting
of 0.067 M phosphate-buffered saline (PBS), pH 7.2,
containing 1% bovine serum albumin
Sigma, St. Louis, MO).

(BSA)

After washing,

(Fraction V;

the wells were

blocked by the addition of 100 jal of 0.0 67 M PBS, pH 7.2,
containing 5% BSA and incubated at 37°C for 1 hr.

The

wells were then washed as before and 50 jal of each serum
sample diluted in wash buffer was added to duplicate wells
in an effective dilution of 1:180.

The plates were sealed,

and incubated at 37°C for 1.5 hr when they were removed,
and washed as before.

Horseradish peroxidase conjugated

IgG fraction of goat anti-human IgM (mu specific)
Cochranville, PA) optimally diluted

(1:4000)

(Cappel,

in 50 jil of
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wash buffer was added to each well.

The plates were then

sealed and incubated for 2 hr at 37 °C, when they were
removed and washed as before.

After washing,

50 jul of a

solution containing 0.4 mg/ml ortho-phenylene-diamine with
0.002% H 2 O 2 in 0.1 M sodium acetate buffer, pH 5.5, was
added to each well.

The plates were incubated at room

temperature for 20 min when the reaction was stopped with
the addition of 50 jul 9 N HCl.

The plates were read for

absorbency at 488 nm on a Beckman DU8B spectrophotometer.
Control absorbent values from wells containing serum but
not receiving antigen were subtracted from serum plus
antigen w e l l s .

The mean absorbent value for each sample

was calculated for use in statistical analysis.
Optimal d i l u t i o n s ;

The optimal dilution of serum

was defined to be that lowest dilution which did not yield
nonspecific absorption greater than 2 times the substrate
control when reacted in blank wells.

Serum was diluted

1:100, 1:400 by two-fold dilutions in the ELISA wash buffer
and reacted with an optimal dilution

(1:4000) of conjugate

(see b e l o w ) .
The optimal concentration of the.M.

leprae Phen-Gl-1

antigen was determined by checkerboard titration.

Positive

and negative armadillo sera were selected on the basis of
known inoculation history with M. l e p r a e .

Conjugate and

sera were used at constant dilutions in an ELISA wash
buffer at 1:4000 and 1:180, respectively.

The Phen-Gl-1

antigen was coated in microtiter plates at concentrations
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of 100 ug/ml with two-fold dilutions to 3 jig/ml.

Coating

and incubations were followed as described before.

The

optimal concentration was defined as that highest dilution
in antigen excess resulting in the greatest difference in
absorbency readings between positive and negative sera.
To determine the optimum range of conjugate for use in
the assay, the conjugate, horseradish peroxidase IgG
fraction of goat anti-human IgM (mu specific), was diluted
two-fold from 1:100 to 1:32000 in an ELISA wash buffer.

A

checkerboard titration was performed across the wells of a
polyvinyl microtiter plate coated with serial dilutions of
human IgM (Cappel, Cochranville, PA)
and 0.1 ng/well.

at 100,

50, 10, 5, 1,

Following incubation and wash procedures

as described above,

the optimum range was defined as those

dilutions of conjugate yielding best linearity in
absorbency readings between 1 and 10 ng of human IgM.
Optimal dilution of conjugate was later determined in
checkerboard titration across the wells of a polyvinyl
microtiter plate coated with 50 jug/ml of Phen-Gl-1 and
reacted with positive and negative serum as delineated
before.

The optimal dilution of conjugate was defined to

be the highest dilution which also yielded the greatest
difference in absorbency readings between the positive and
negative sera.
Mycobacterial spe c i e s :
species

Cultivable mycobacterial

(M. scrofulaceum, M. p h l e i ) were inoculated to

Lowenstein-Jensen

(L-J) slants and grown to confluency.
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The organisms were harvested using H a n k s 1 balanced salt
solution (HBSS) and pelleted via centrifugation 2000 x g
for 10 minutes.

They were subsequently washed 5 times with

HBSS and enumerated (182).

^he organisms wer e aliquoted to

separate tubes such that each tube contained 1 x 1 0 9
bacteria.

They were pelleted by centrifugation and the

supernatants discarded.

M. leprae w e r e propagated in

armadillos and harvested from tissues by manual teasing
into 1 gm pieces.

Tissue and bacteria were separated by

differential centrifugation in HBSS and the supernatants
were saved.

Supernatants containing M. leprae wer e then

pelleted by centrifugation and washed 5 times with HBSS.
Organisms were enumerated and aliquoted to separate tubes
such that they would contain 1 x 1 0 9 M. leprae after
supernatants were removed.
Absorption of s e r a ;

Selected serum samples were

absorbed with the mycobacterial species.

Sera diluted

1:180 in 400 jul of EL I S A was h buffer were added to the
tubes containing 1 x 10 9 pelleted mycobacteria.

Pellets

were resuspended by gentle shaking every 15 min while the
tubes wer e incubated for 1 hr at 37 °C.

The tubes were then

held overnight at 4°C, and the suspensions were clarified
by centrifugation before use.

The absorbed supernatant

serum was then assayed by the ELISA as described previously.
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RESULTS

Cross reactivity of human and armadillo I g M ;
Human IgM and armadillo IgM are serologically cross
reactive.

Crossed immunoelectrophoresis

(CIEP)

of

armadillo whole serum into a second dimension containing
rabbit anti-armadillo globulins produced a typical CIEP
pattern with multiple lines of precipitation

(Fig. 3.1a).

While CIEP into a second dimension containing peroxidase
conjugated goat anti-human IgM (mu chain specific)
demonstrated a single precipitation line of slow migration
like that of IgM

(Fig. 3.1b), other armadillo serum

proteins were not detected with the anti-human IgM
peroxidase conjugate.
Optimization of E L I S A ;

For the ELISA,

the lowest

serum dilution was selected which did not result in
excessive nonspecific binding of immunoglobulins to the
carrier surface.

As shown in Figure 3.2a, serum dilutions

less than 1:180 resulted in nonspecific binding to the
solid phase > 2.5 times the substrate control.

Sera

diluted 1:180 avoided this nonspecific binding and was
selected as optimal.
Optimal proportions of antigen and antibody aid in the
sensitivity of the assay.

As shown in Figure 3.2b, coating

wells with 2 jug of Phen-Gl-1 resulted in antigen excess
while allowing maximum dilution of the antigen in the
system.
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A maximum conjugate dilution of 1:4000 yielded the
greatest difference of absorbency readings between positive
and negative samples {Figure 3.2c).

This dilution did not

result in nonspecific absorption of conjugate to the solid
phase.

This conjugate dilution also showed linearity of

reaction between 1 and 10 ng of human IgM (data not shown).
ELISA of control g r o u p :

Seventy-six plasma

samples from armadillos housed at the National Hansen's
Disease Center armadillo farm were assessed.

The results

are illustrated in a frequency histogram (Figure 3.3a) and
a scattergram (Figure 3 . 3 b ) .

When the sample was examined,

over 10 equal class intervals of 2 0 0 absorbent units each,
an apparent bi-modal distribution was revealed
3.3a).

(Figure

When the population was more closely scrutinized in

a scattergram, the apparent separation in absorbency
readings along the continuum creating two groups was shown
to be distinct.

Multivariate discriminant analysis showed

this separation to be statistically significant (p < 0 .0 0 1 ;
N = 5 2 , N=23)

(36,192)

(Fig. 3.3b).

The boundaries of the

two groups as demarked by two standard deviations around
their respective means created an equivocal zone.

It was

considered that points falling within the equivocal zone
could not reliably be ascribed to either of the two groups.
The data points were then pooled and analyzed
according to their known experimental inoculation history
with M. leprae (i.e., months post-inoculation)
appearance of acid-fast bacilli

{AFB)

and

in peripheral blood,
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buffy coat cells.

Points falling above the equivocal zone

were predominantly (48/52)

from armadillos known to have

been experimentally inoculated with M. leprae (Figure 3.4).
All samples from armadillos with acid-fast bacteria in
their buffy coat smears appeared above the equivocal zone.
Of those points falling below the equivocal zone, 16 of 23
animals were not experimentally inoculated with M. l e p r a e ,
while the remaining 7 were known to have been inoculated
with M. l e p r a e .
to the infection.

One animal was considered to be resistant
The single point falling within the

equivocal zone also was derived from an animal considered
resistant.

Thus, the points falling above the equivocal

zone represent sera from animals with detectable IgM
antibodies to Phen-Gl-1, and were considered "positive".
Those below the zone did not have detectable IgM antibodies
to Phen-Gl-1 and were considered "negative".

Animals not

manifesting AFB appear on both sides of the zone, while
those demonstrating AFB grouped only above the zone.
Regressional analysis was performed for AFB positive and
AFB-negative animals with time after experimental
inoculation.

Both groups regressed significantly and their

slopes appeared to be different, showing the ELISA to be
semi-quantitative and suggesting a difference in the rates
of antibody development in the two g r o u p s .
Four armadillos not experimentally inoculated with M.
leprae also appeared in the positive group.

One of these

armadillos presented from the wild with an acid-fast
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bacterial infection indistinguishable from M. l e p r a e .
Absorption of these four sera with whole M. leprae
significantly reduced <p = 0 .0 0 1 , paired t test)
antibody reactivity.

the

Absorption with M. scrofulaceum and

M. phlei did not significantly alter the antibody
reactivity of these sera {Figure 3.5).
ELISA IgM vs. Phen-Gl-1 quality p a r a m e t e r s :
serological parameters of sensitivity,

The

specificity,

efficiency, and predictive value for positives

(79) W ere

calculated for the ELISA IgM vs. Phen-Gl-1 based on the
available data.

As shown in Table 3.1, the assay correctly

detects IgM antibodies in an armadillo with a known
previous experience with M. leprae 100% of the time
{predictive value of positive).

With a 95% confidence,

the

assay offers a sensitivity of 89%, a specificity of 100%,
with an overall efficiency of correctly identifying the
infectious experience of an armadillo 90% of the time.

DISCUSSION

These data indicate that an enzyme-linked immunosorbent
assay incorporating cross reactive antisera for human IgM
and the Phen-Gl-1 antigen correlates with, and therefore
m ay be used to assess the immunological experience of
armadillos with M. l e p r a e .

The ELISA-IgM vs. Phen-Gl-1

avoids problems of nonspecific reactivity found in assays
using undefined antigen mixtures, and allows detection of
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IgM class antibodies to M. l e p r a e .

The assay is an

efficient (90%) tool for serological investigations of M.
leprae in armadillos, and affords sensitivity (89%) and
apparent specificity (1 0 0 %) heretofore unreported for
serological assays in leprosy (196),
Serological cross reactivity of human IgM has been
noted in several other species including cows, monkeys and
sharks

(74),

use of commercially prepared reagents in

immunoassays allows for their wider application in other
laboratories.

Armadillo antisera are not commercially

available, but armadillo IgM has substantial serological
cross reactivity with human IgM.

Fortunately,

therefore,

commercially prepared anti-human IgM second antibody enzyme
conjugates are satisfactory for use in ELISA assays for
armadillo IgM antibodies.
Serological screening tests m ust distinguish samples
as positive or negative.

To do so, the descriptive limits

of positive and negative must be defined and the assays
must be optimized to avoid nonspecific reactivity.

By

screening sera from 7 6 armadillos of known inoculation
history with M. l e p r a e , statistical limits for positive and
negative have been derived for the ELISA IgM vs. Phen-Gl-1.
Sera from this group may now be used as standards in
subsequent screenings to allow the interpretation of new
results as positive or negative.
Screening of the test group showed that 87%

(49/56) of

the animals experimentally infected with M. leprae had
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detectable IgM antibody to the Phen-Gl-1 antigen.

Of the 7

armadillos experimentally inoculated with M. leprae but not
demonstrating detectable antibody,
animals.

two were from resistant

Approximately 10% of the armadillos

experimentally infected at the National Hansen's Disease
Center are resistant to M. leprae - they do not succumb to
lepromatous disease (95).

Resistance in leprosy is

governed by cell-mediated immunity (96) #

Humoral immunity

may not be mustered in these resistant animals.

Further

investigation is needed to determine if serological
monitoring of armadillos may be useful in the early
identification of resistant and susceptible animals.
Antibody profiling of armadillos experimentally
infected with M. leprae will aid in their development as
animal models in leprosy research

(60,99)^

previous

efforts to detect M. leprae antibodies in armadillos have
exercised traditional RIA methodologies with iodinated
fractions of the sonicated whole bacillus

(6 6 ) #

Those

reports indicated that IgG antibodies to M. leprae became
detectable only simultaneously with the appearance of AFB
in the peripheral blood (64)#

Experimentally infected

armadillos both with and without acid-fast bacteria in the
peripheral blood had detectable IgM antibodies to the
Phen-Gl-1 antigen.

These ELISA data suggest that IgM

antibodies to the Phen-Gl-1 antigen are detectable well in
advance of overt systemic infection.

These antibodies

appear to be chronically synthesized over the course of
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infection and are present in comparatively high
concentrations until the animals are sacrificed.
Therefore, IgM class antibodies to the Phen-Gl-1 antigen
appear to be good indicators of subclinical or early
leprosy, and may be the more appropriate isotype for
sero-epidemiological investigations.
Other investigators using the Phen-Gl-1 antigen in
ELISA assays of human sera have reported approximately a 4
to 5% apparently "false-positive"
control groups.

rate in presumed negative

These reports are based on resulting ELISA

absorbancies above 0.1 in traditional ELISA methodologies
used on the sera of individuals from leprosy nonendemic
areas and exhibiting no clinical signs of leprosy

(23) #

Wild armadillos have been reported to harbor a
mycobacterial infection indistinguishable from M. leprae
(210)_

our test group contained 4/20 samples from 4

recently captured armadillos not inoculated with M. leprae
which yielded ELISA absorbancies statistically
interpretable as positive.

When these sera were absorbed

with M. l e p r a e , their ELISA reactivity was significantly
reduced, while absorption with M. phlei and M. scrofulaceuro
did not significantly alter their ELISA reactivity.
Presumably, therefore, these are true positive reactions
suggesting that modern day wild armadillos in Louisiana
may have an M. leprae antibody prevalence rate as high as
20%.
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In conclusion,

the serology of mycobacterial diseases

is complicated by the plethora of cross reacting antigens
found among the various species.

Isolation of an

apparently species-specific antigen for M. leprae has
allowed the development of serologic tests with high
specificity.

Antibody profiling of experimentally infected

armadillos will aid their development as animal models for
leprosy and better descriptions of M. leprae infections in
wild armadillos, as measured serologically, may well
provide a better understanding of the transmission of
leprosy in humans.

ACKNOWLEDGMENTS
W e would like to thank Mr. J. L. Allen and Mr. J. p.
Pasgua for their technical aid in this project, Dr. Darrel
Gwinn from NIAID for the Phen-Gl-1 antigen used in this
study, and Mrs. Renee Painter for her excellent secretarial
assistance.

This work has been supported in part by a

grant from the American Leprosy Missions.

53

Table 3.1
Elisa-IgM v. Phen-Gl-1 quality parameters
Parameter

Ratio

Percent

Sensitivity

53

53 (true+)
(true+) + 6 (false-)

89

Specificity

16 (true-)
16 (true-) + 0 (false+)

10 0

Efficiency

53 (true+) + 16 (true-)
76 (N)

90

predictive
of Positive

53

53 (true+)
(true+) + 0 (false+)

100

True+ = Absorbance > 710 and known inoculation with
M. leprae or absorbable Phen-Gl-1 antibody.
True- = Absorbance < 560 and no known history with M.
leprae.
False+ = Absorbance > 710 with no known history with
M. leprae and unabsorbable antibody to Phen-Gl-1
False- = Absorbance < 710 with known inoculation of
M. l e p r a e .
* Known resistant animals are not included.
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Table 3.2
Legends to figures

Figure 3.1 Crossed immunoelectrophoresis of whole armadillo
serum.

A) Second dimension contains rabbit

anti-armadillo i m m u n o g l o b u l i n s . • B) Second
dimension contains horseradish peroxidase
conjugated IgG fraction goat anti-human IgM (mu
chain specific).

Figure 3.2 Optimal dilutions for ELISA.

3.2A) Absorbance

(488 nm) resulting from nonspecific absorption
of IgM to polyvinyl microtiter plates at various
dilutions of armadillo serum.

3.2B) Absorbance

(488 nm) resulting from positive pooled control
serum reacting with various concentrations of
Phen-Gl-I coated to wells of polyvinyl
microtiter plates showing optimal dilution to be
25 ug/ml.

3.2C) The difference in absorbance

(488 nm) between control positive and negative
antisera reacted with 25 ug Phen-Gl-I coated
microtiter plates detected by various dilutions
of horseradish peroxidase conjugated IgG
fraction goat anti-human IgM (mu chain specific).
SUBSTRATE ABS = substrate absorbance.
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Figure 3 3 Distribution of ELISA absorbance of 76
armadillos with known experimental inoculation
history.

4A) Frequency histogram showing number

of samples occurring in each of 1 0 absorbance
classes and demonstrating apparent bimodality.
4B) Scatter plot of ELISA absorbances showing
significant difference, p < 0 .0 0 1 ) in means of
the two groups and demarcation of equivocal
zone.

Figure 3 4 Regression of ELISA absorbances according to the
presence
(AFB)

(*) or absence (o) of acid-fast bacilli

in peripheral blood.

* = acid-fast

positive; o = acid-fast negative; R = resistant
armadillos.

Figure 3 5 ELISA absorbance (488 nm) of 4 suspected false
positive armadillo sera after absorption with M.
l e p r a e , M. scrofulaceum and M. p h l e i .

Equivocal

zone is demarcated by solid horizontal bars.
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Figure 3.1
Crossed Immunoelectrophoresis of
Armadillo Whole Serum in the First
Dimension against (a) Anti-Armadillo
Whole Serum; or (b) Horseradish
Peroxidase Conjugated Anti-Human IgM
(mu specific) in the Second Dimension.
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Chapter 4: Abstract
Using an enzyme-linked immunosorbent assay that
detects armadillo IgM class antibodies to the apparently
species-specific phenolic-glycolipid-1

(Phen-Gl-1) antigen

of M. l e p r a e , a retrospective serological survey was
performed.

Sera from 182 armadillos taken in the years

19 60 to 1964 and predating the use of armadillos in leprosy
research were tested.

Antibodies to the Phen-Gl-1 antigen

were detected in 17 of the sera.

Absorption with whole M.

leprae significantly reduced the antibody activity of the
sera.

Absorption with M. a v i u m , M. intracellulare, M.

scrofulaceum, BCG, M. dienrh o f e r i , M. p h l e i , M. r hodesiae,
M. t er r a e , M. k a n s a s i i , and two new mycobacterial isolates
from armadillos 8152 and 8480 failed to significantly alter
the antibody activity of these sera.

These antibodies

presumably indicate that wild armadillos experienced
infections with M. leprae as early as 1961.
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Man has traditionally been thought to be the only
natural host of Mycobacterium l e p r a e , the etiological agent
of leprosy.

However,

studies beginning in 1968

demonstrated that the nine-banded armadillo (Dasypus
novemcinctus) is susceptible to experimental infection with
M. leprae (97).

since 1975, a number of reports have

appeared which establish that wild armadillos harbor a
mycobacterial infection indistinguishable from M. leprae
(14,184,185,210,2 l l ) #

Recently, five cases of human

leprosy have been reported in individuals from Texas, whose
only contact with M. leprae may have been through long-term
close association with armadillos

<H O )_

Thus, the

discovery of M. leprae in the wild armadillo has not only
raised many questions about the transmission and host range
of leprosy, but identified a possible public health risk.
How the armadillo became infected with M. leprae is
central to a better understanding of the transmission of
leprosy.
proposed:

Generally, three possible answers have been
a) M. leprae may be natural to the armadillo and

indigenous to the population

(2 1 2 ) or armadillos may have

acquired leprosy either by b) association with infected
humans or c) inadvertent environmental contamination from
experimentally infected armadillos sometime since 19 68
(183).
We recently developed an enzyme-linked immunosorbent
assay (ELISA)

that detects armadillo IgM antibodies to the

apparently species-specific phenolic glycolipid antigen
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(P h en- G l - 1 ) of M. leprae

(ELISA-IgM vs. Phen-Gl-1)

d 9 8 >.

We report here an evaluation of the post-19 68 environmental
contamination hypothesis for the origin of M. leprae
infections in wild armadillos.

MATERIALS AND METHODS
Wild armadillo sera 1 9 6 0 - 1 9 6 4 ;

A total of 182

armadillo serum samples were collected by Adams and Roth in
1960-1964 as part of a survey for leptospires in wild
animals

(165,166,167)#

The samples were tested for

leptospiral antibodies and stored at - 1 0 °C for
approximately 1 2 years when they were deposited in the
Louisiana State University School of Veterinary Medicine
serum bank and stored at - 7 9 °C.

Information relative to

sex, time, date, location of capture, known antibody titers
and previous users was recorded for each serum.
Leptospiral s e r o l o g y ;

in 1983 the Louisiana

Veterinary Medical Diagnostic Laboratory (L V M D L ) repeated
leptospiral antibody titration on armadillo sera that had
been found to be positive in 19 60-19 64.

The modern

leptospiral method employed by the LVMDL uses a
microtitration technique with commercially prepared
antigens and control sera.

The initial dilution for a

positive sample by the LVMDL procedure was 1:100.

The

procedure originally used by Adams and Roth in 19 60-19 64
was a tube agglutination method with individually prepared
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antigens and 1:25 as a minimum dilution for a positive
serum.
Antigen:

Native,

pure phenolic-glycolipid-1

(Phen-Gl-1) was prepared by Dr. Patrick Brennan (Colorado
State University) and obtained through contract with the
National Institute of Allergy and Infectious Disease, Dr.
Darrel Gwinn, Project Officer.
ELISA—IgM vs. P h e n- G l - I i

An enzyme-linked

immunosorbent assay (ELISA) was performed according to the
method described previously (198).
Mycobacterial s p e c i e s ;

Mycobacterial strains 8152

and 8480 are "difficult to grow" isolates arising from the
tissues of armadillos.
Portaels

They were a gift from Dr. Francoise

(Prince Leopold Institute of Tropical Medicine,

Antwerp, B e l g i u m ) .

Cultivable mycobacterial species

(M.

a v i u m , BCG, M. d i e r n h o f e r i , M. intracellulare, M. k a n s a s i i ,
M. p h l e i , M. r h o d e s i a e , M. s c r o f ulaceum, M. t e r r a e , and
Portaels'

bacilli 8152 and 84 80 were inoculated to

Lowenstein-Jensen

(L~J) slants and grown to confluency.

The organisms were harvested using Hanks'
solution

balanced salt

(HBSS) and pelleted via centrifugation at 700 x g.

They were subsequently washed 5 times with HBSS and
enumerated

(182)^

Bacterial suspensions were diluted to

contain 1 X 10 9 organisms per ml in 0.067 M phosphate
buffered saline (PBS) with 1% bovine serum albumin
(PBS/BSA),

pH 7.2.

M.

leprae were propagated in
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armadillos,

harvested as described previously

(215) an(j

likewise diluted in PBS/BSA.
Absorption of s e r a ;

Enumerated bacterial

suspensions were aliquoted to disposable microfuge tubes
(Beckman Instruments, Palo Alto, CA)

in 200 .pi volumes at a

concentration of 1 x 10^ organisms/ml.

Serum samples with

ELISA absorbances interpretable as positive were diluted
1:180 in PBS/BSA and added in 200 p i volumes to tubes
containing mycobacteria or PBS/BSA alone.

Sera and

bacteria were mixed by gentle shaking every 15 min as the
tubes were incubated for 1 hr at 37°C.

The tubes were then

held overnight at 4°C, and the suspensions were clarified
by centrifugation on a Beckman Microfuge model B for 5 min
before use.

The absorbed serum was assayed in the ELISA as

described above.
RESULTS
Wild armadillo serum 1960-1964
History:

Armadillo serum samples collected in

1960-1964 originated from a six-parish area of the
Atchafalaya Basin in south central Louisiana.

The area is

located, wes t of the Mississippi River and north
approximately 40 miles from both the Gulf South Research
Institute in New Iberia, Louisiana, and the National
H a n s e n ’s Disease Center in Carville, Louisiana.

The Basin

is a wil d swamp area with mixed habitat and hosts abundant
wildlife.

It is similar in habitat but different in

location to the site of the original report of M. leprae in
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wild armadillos by Walsh, et al.

(210) ^

Atchafalaya

holds soils common to the Louisiana delta region with pH
ranging from mildly acidic (5.0)
(188).

to slightly alkaline (7.7)

rphe Sp ec ific capture site of each armadillo could

be identified within 1 0 0 yards and the collection area is
mapped in Figure 4.1.

Histological sections of kidneys

from 50 of these armadillos were examined in 1973 by
Stewart and Crowell

(195).

Acid-fast bacilli were not

observed in the tissues examined.

Liver tissues were not

examined.
Utility of pre-susceptible sera after 20 years of
storage;

Armadillo sera taken in 1960-19 64 were

evaluated for usability after 20 years of storage.
Leptospiral serology was repeated on the 11 known positive
samples.

The modern leptospiral technique employs a

microtitration method with commercially prepared antigens
and standardized antisera.

The technique of 20 years ago

utilized tube agglutination with individually prepared
antigens.

Initial dilutions of the two techniques also

differ and, therefore, direct correlation of titer results
between the two methodologies is not possible.

However,

positive and negative correlations are still feasible.

As

shown in Table 4.1, 7 of the 11 armadillo sera known to be
positive for Leptospira species retained their antibody
activity after 20 years of storage.

None of the tested

sera changed in antibody specificity to the individual
leptospiral antigens,

a proportion

(4/11) of the sera lost
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all detectable antibody activity over the 20 years of
storage.
ELISA;

The 182 wild serum samples taken 4-8

years before initial susceptibility studies of armadillos
to M. leprae were performed in 1968, were screened in the
ELISA IgM vs. Phen-Gl-1.

The absorbances of these samples

were inspected in a frequency histogram which displayed a
positive skew (Figure 4.2).

Resulting absorbances were

judged according to the definitions of positive and
negative as previously determined (198)^ an(j 17 samples
exhibiting absorbance readings above 0.720 were classed as
presumptive positive.
Absorption of antibody a c t i v i t y :

The 17 presumed

positive sera were absorbed with whole M. leprae and 11
other heterologous mycobacterial species.

The ELISA was

repeated and the absorbance results were analyzed by paired
t-test for significance.

As shown in Figure 4.3, as a

group the 17 sera were significantly (p < 0.001) depleted
of detectable antibody reactive with Phen-Gl-1 after
absorption with whole M. l e p r a e .

As a group the ELISA

absorbances were not significantly altered when absorption
was performed with other mycobacterial species.
absorbances of a highly positive control

ELISA

(+) serum derived

from an armadillo experimentally infected with M. leprae
followed an identical pattern.
control

Absorbances of a negative

(-) serum remained unchanged.
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DISCUSSION
The discovery of M. leprae in the wild armadillo
created controversy concerning the origin, transmission and
host range of leprosy.

Whether M. leprae is indigenous to

armadillos, or wild armadillos acquired M. leprae either
by association with infected humans or contact with M.
leprae contaminated materials some time since the 19 68
armadillo susceptibility trials, has been widely
debated

(183).

evaluated the 1968 environmental

contamination hypothesis by means of a retrospective
serological survey.

The sera from 182 wild armadillos

taken in years (19 60-64) pre-dating the 19 68 susceptibility
trials were examined for IgM antibodies to the Phen-Gl-1
antigen of M. l e p r a e .
Antibody to the apparently species-specific phenolic
glycolipid antigen

(Phen-Gl-1)

of M. leprae

(22,33,78) was

detected in 17 of 182 sera taken from wild armadillos in
1960-64.

Reactivity of these antibodies was significantly

reduced by absorption with whole M. l e p r a e .

This

reactivity was not significantly altered by absorption with
11 other mycobacterial species tested (Fig. 4.3).

The

absorption scheme sought to eliminate antibodies that might
have been induced by some "Original Mycobacterial Sin"
Members of the MAIS antigenic complex (12)

(4).

(m . a v i u m , M.

intrace l l u l a r e , M. scrofulaceum) and BCG may potentiate the
immunologic response to M. leprae ( H )
antigens

(137).

and may hold common

Additionally, common soil mycobacteria,
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represented here by M. diern h o f e r i , M. p h l e i , M. rhodesiae,
and M. t e r r a e , may also induce this phenomenon.

M.

kansasii is known to share a common phthicerol core antigen
with M. leprae (81) an<j other, as yet unrecognized,
mycobacterial species

(represented here by P o r t a e l s 1

bacilli 8152 and 8480 isolated from armadillo tissue)
also function in this area.

could

Failure by these species to

absorb the antibody activity to the apparently
species-specific Phen-Gl-1 antigen suggests that those
antibodies were elicited as a result of exposure to M.
leprae.
Long-term storage of serum samples may result in
protein deliquescence,

antibody aggregation, or loss of

antibody reactivity (185)^

rp0 assure the utility of these

182 sera after 20 years of storage,
activity was reassessed.

leptospiral antibody

Since technical methodologies of

leptospiral serology have changed in 20 years, direct
correlation of titer results was not possible.
could only be judged as positive or negative.

Results
A proportion

(4/11) of these sera apparently had lost leptospiral
antibody activity over the years of storage (Table 4.1).
Since the true proportion of sera that had lost reactivity
could not be discerned,

it was not possible to describe

prevalence rates in the 19 60-19 64 population.

However,

none of the serum samples previously negative for
Leptospira species antibodies was found to be positive
after 20 years of storage.

These sera maintained their
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specificity and had utility for seroepidemiological
investigation.
Adams and Roth collected these sera along with
visceral tissues from 182 armadillos in the Atchafalaya
Basin of south central Louisiana during the years 1960-1964.
Samples were collected as part of a survey for leptospires
in Louisiana wildlife.

After testing, the materials were

stored frozen for future reference.
Crowell

In 1973, Stewart and .

(195) examined sections of kidneys from 50 of these

armadillos but failed to detect acid-fast bacteria.
Armadillos experimentally infected with M. leprae at the
National Hansen's Disease Center rarely express acid-fast
bacteria in renal tissues

(173)r ana the failure of Crowell

and Stewart to detect acid-fast bacteria in these kidney
tissues should not be considered unusual.
Certain environmental associations have been made with
leprosy infections in humans, and there appear to be trends
to higher prevalence rates in humid climates

(80)#

Kazda

recently reported isolation of a leprosy-like organism from
a peat bog in Norway having a pH of 5.5

(92)^

Such mildly

acidic soil pH conditions have been identified as optimal
for isolation of some mycobacterial species from soils
(10,190)a

The Atchafalaya Basin is a wild swamp area and

soils of the region are typical to the delta of Louisiana,
ranging in pH from 5.0 to 7.7 depending upon drainage.

No

reports have been made of attempts to isolate M. leprae or
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leprosy-like organisms from soils of the Atchafalaya,

but

such investigations may be warranted.
Antibodies may be regarded as highly specific
indicators of infectious experiences.

The presence of

antibodies to the apparently species-specific Phen-Gl-1
antigen in armadillos during the years 1960-19 64 suggests
that M. leprae was present in the wild population before
the armadillo was used as an experimental host for M.
leprae cultivation.

Presumably then, the original

infection of wild armadillos with M. leprae could not have
resulted from any inadvertent environmental contamination
associable with the 19 68 armadillo susceptibility trials or
any subsequent experimentation with armadillos.

The true

origin of M. leprae infection in the wild armadillo
remains an important scientific question.

If the infection

was not the result of accidental contamination, how have
armadillos contracted leprosy?

An understanding of the

origin of this infection in armadillos may have
considerable impact on our understanding of the
transmission of leprosy in humans.
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Table 4.1
Reassessment of 19 60-19 64 wild armadillo
leptospiral serology after 20 years of storage
Sample

9

Canicola
pre now

Grippota
now
pre

Pomona
pre now

Icteroh *5
pre
now

400

400

•

*

100

•

•

*

•

19c

•

•

•

100

•

34

•

1 00

•

10 0

•

36

•

100

400

•

•

96

400

•

•

10 0

•

10 6 d

■

•

•

25

200

100

*

118

*

100

■

•

«

100

200

165d

*

«

■

25

100

•

•

208

•

.

100

1 00

•

*

•

•

209d

■

m

100

100

25

*

14

.

a=Grippotyphosa
b=Icterohemorrhagea
Four culture positive when captured
c L. pomona
d L. autumnalis

100

25

100
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Table 4.2
Legends to figures
Figure 4 1 Map of general capture area where 182 wild
armadillos were taken by Adams and Roth in the
years 19 60 to 19 64.

Figure 4 2 ELISA absorbances of 182 wild armadillos taken
in the years 19 60 to 19 64 plotted in a frequency
histogram of equal class intervals.

Figure

demonstrates positive skew of sample group.

Figure 4 3 ELISA absorbances of presumed positive wild
armadillo sera collected in the years 19 60 to
19 64 and absorbed with various mycobacterial
species.

Absorption with whole M. leprae

resulted in significant

(paired-t; p < 0 .0 0 1 )

reduction in ELISA absorbances.

Absorption with

other mycobacterial species not significant.
Point(+) = control positive serum; point(-) =
control negative serum; point 1-17 = serum
samples from 1960-19 64 wild armadillos.
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Chapter 5, Abstract:
Sera from 216 wild armadillos of two parishes in
south central Louisiana and Florida were tested by ELISA
for IgM antibodies to the phenolic-glycolipid - 1 antigen of
M. l e p r a e .

Antibodies were not detected in sera from

Florida armadillos

(0/30).

Louisiana armadillos had an

antibody prevalence rate averaging 12.5%

(23/186).

Antibody prevalence rates between Louisiana and Florida
were significantly different.

Antibody prevalence rates of

armadillos of the two Louisiana parishes were similar.

The

clinical disease rate was estimated to be 2.7% for
Louisiana armadillos by histologic examination to detect
disseminated acid-fast bacteria.

The population

characteristics and environmental conditions of the
Louisiana leprosy positive habitat were described.

Future

comparisons of prevalence rates in armadillos of different
habitats will aid in understanding the transmission of
leprosy and further develop the armadillo as an animal
model for leprosy research.
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The transmission of leprosy is not yet understood. It
is suspected to be obligately transmitted from man to man
and may require long term close contact with infected
humans

(58).

However, other mechanisms have been

implicated. Environmental conditions have been described
that correlate with increased prevalence rates of
leprosy (80) and Kazda has reported isolation of an
M. leprae-like organism from a sphagnum bog in Norway (92),
Mycobacteria sharing certain phenotypes with M. leprae may
be found in nature. The role of environment or
environmental microorganisms as pathogens or additional
factors influencing the transmission of leprosy has not
been determined

(190,191),

^ better understanding of these

influences may aid in the control of leprosy.
Epidemiologic studies on the transmission of leprosy
in man are complicated by low susceptibility and mobility
of the human population. However,

leprosy is zoonotic in

the nine-banded armadillo (Dasypus novemcinctus)
(14,185,186,210 ,2 1 1 ) f an(j approximately 90% of armadillos
are susceptible to leprosy (95,96),

Thus armadillos may be

used as an animal model to study the transmission of
leprosy.
To effectively use the armadillo as an animal model,
large groups must be sampled with sensitive screening
techniques and relevance must be given to the environment
and population characteristics of the groups studied.
Previous investigations of leprosy in wild armadillos have
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relied on histologic examinations to detect disseminated
acid-fast bacteria. The leprosy-like disease has been
confirmed in various locales and prevalence rates have been
estimated to range from 0 to 25%

(14,185,186,210,211)^

Such disparate estimates may be the result of insensitivity
of the histologic screen, population characteristics or
environmental conditions.
We recently developed an enzyme-linked immunosorbent
assay (ELISA) that detects armadillo IgM antibodies to the
phenolic-glycolipid-1
(198)#

(Phen-Gl-1)

antigen of M. leprae

This antigen is chemically defined and apparently

species specific for M. leprae (22,33,78)_ Antibodies to
this antigen may be detected in the absence of
disseminated disease (198)_

^e report here preliminary

data assessing IgM anti-Phen-Gl-1 antibody prevalence rates
in wild armadillos of Louisiana and Florida, and a
description of a leprosy positive armadillo habitat.

MATERIALS AND METHODS

Serum and histologic s a m p l e s ; Armadillos were
captured in 2 parishes of south central Louisiana:
Iberville and Point Coupee. A total of 131 armadillos from
Iberville parish were taken by local trappers in the
vicinity of Sunshine, Louisiana and brought to the National
Hansen's Disease Center (NHDC)

in Carville, Louisiana.

At

the NHDC armadillos were sampled by venipuncture and snips
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of ears were taken for histologic examination to detect
acid-fast bacilli

(AFB). A total of 55 different armadillos

in Point Coupee parish were sampled in the field near Krotz
Springs, Louisiana and along a tract where 2 armadillos
sero-positive for leprosy had been taken in the years
1960-64

(see preceding chapter).

Field serologic samples

were taken in capillary tubes after the excision of a
toenail.

A sample of ear was taken before the animals were

released.
Serum samples from 30 Florida armadillos were
collected by Dr. E. Storrs
Technology)

(Florida Institute of

and provided as a gift through the National

Institute of Allergy and Infectious Diseases

(Dr. Darrel

Gwinn, Program Officer).
Population D e n s i t y ; Armadillos in Point Coupee
Parish were captured over a 10 mile stretch of levee
bordering the Atchafalaya River and comprising an area of
approximately 200 ha (500 acres). Using a system of
capture-mark-recapture the total population was estimated
by the Lincoln-Peterson method:

[(total number of marked

and unmarked animals taken on the final trapping day) X
(total number of animals marked)] / (total number of
previously marked animals recaptured on the final trapping
day)

(108) ^

T jie population density was the ratio of total

population/area sampled.
Antigen:

Native purified phenolic-glycolipid-1

(Phen-Gl-1) was prepared by Dr. Patrick Brennan

(Colorado
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State University)

and obtained through contract with the

National Institute of Allergy and Infectious Diseases

(Dr.

Darrel Gwinn, Project Officer).
ELISA;

Enzyme-linked immunosorbent assay (ELISA)

was performed according to the method described
previously (198).
Histology:

Tissue was prepared by standard

methods as reported previously and examined for the
presence of acid-fast bacteria (AFB)

in nerves

(8 6 ) #

RESULTS

Capture a r e a ;

Armadillos were taken from 2

parishes in Louisiana:

Iberville and point Coupee. The

parishes border, but specific capture areas were some 40
miles apart. The Point Coupee site was a tract along the
Atchafalaya River while Iberville bordered the Mississippi
River.

Both parishes provided excellent habitat and hold

abundant wildlife. A total of 49 animals were marked in the
Point Coupee area and 1 was recaptured on the final
trapping day.

Using the Lincoln-Peterson method of

capture-recapture (108) the population density in Point
Coupee was estimated to be 5 per 7 acres.
Iberville was not calculated.

The density in

Average climatic conditions

of the 2 parishes were also similar

(Table 5.1): annual

rainfall 54.9", relative humidity 73.7%, yearly temperature
69°F.

Neither of the parishes had been inundated by floods
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since 1973 (35) ^
poorly drained.

areas where armadillos were taken were
Soils of the two areas were only slightly

different with Convent types

(coarse-silty, mixed,

thermic

aerie fluvaquents, pH 5.6 to 8.4) predominating Point
Coupee; and Commerce types

(fine-silty, mixed, thermic

aerie fluvaquents, pH 5.6 to 7.8) predominating Iberville
(186,187)#

conditions occupied by Florida armadillos

were unknown.
Antibody p r e v a l e n c e :

A total of 186 serum samples

taken from armadillos in Louisiana (131 Iberville,

55 Point

Coupee) and 30 samples from Florida armadillos were
screened by ELISA for IgM antibodies to Phen-Gl-1. The
resulting absorbances were judged according to definitions
of positive and negative as previously determined for the
ELISA (198)

(Fig. 5.1).

A total of 23

(12.5%) Louisiana

armadillos had detectable IgM antibodies to Phen-Gl-1.
Antibodies were detected in 10.7%

(14/131) of the

armadillos from Iberville parish and 16.3%
the armadillos from Point Coupee.

(9/55) of

None of the Florida

armadillo sera had detectable IgM antibodies to Phen-Gl-1.
Antibody prevalence rates from the various groups were
compared for significant differences by Chi square (Table
5.2). Armadillos from Iberville and Point Coupee were not
significantly different. However, antibody prevalence rates
of Louisiana and Florida armadillos were significantly
different

(p < 0.05).
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Histologic p r e v alence:

Leprosy prevalence rates

for Louisiana armadillos were also described by histologic
methods.

Acid-fast bacteria (AFB) were detected in 2.7%

(5/186) of the Louisiana animals. Armadillos from both
parishes presented with detectable AFB in ear tissues: 3
Iberville,

2 Point Coupee. Each armadillo with detectable

AFB also had positive serologic findings. However,

18

armadillos from both parishes had detectable IgM antibodies
to Phen-Gl-1 without manifesting detectable AFB.

DISCUSSION

To effectively use the armadillo as an animal model
for the transmission of leprosy; large populations must be
sampled with sensitive screening methods and relevance must
be given to population characteristics and environment of
the groups under study,

previous studies of leprosy in the

wild armadillo have relied on histologic methods to
identify infected animals.

Histology alone may lack

adequate sensitivity to describe leprosy prevalence rates
in armadillos.

Acid-fast bacteria may only be detected in

armadillos once infection has established and disseminated.
Therefore histology is a measure of clinical disease.
Examination of ear tissues from Louisiana armadillos
indicated clinical leprosy in only 2.7%
animals examined.

(5/186) of the

Previous reports using histology to

describe the prevalence of leprosy in Louisiana armadillos
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have also averaged only 4.9%

(116),

However,

the ELISA

suggest armadillos may have a greater experience with
leprosy,

prevalence rates for IgM antibodies to Phen-Gl-1

averaged 12.5% in Louisiana armadillos. This lipid antigen
promotes a predominate long term IgM response (24,198,217),
Antibodies may be elicited after exposure to antigen or
early in the course of infection.

Thus, the ELISA is a

better reflection of sub-clinical and antigenic
experiences. Used in combination,

these methods should

provide adequate sensitivity to investigate leprosy in the
wild armadillo.
The population characteristics operated by different
groups of armadillos may influence their observable
prevalence rates. If leprosy is obligately transmitted from
armadillo to armadillo, then groups with greater density
might have higher prevalence rates, those with lower
density,

lower rates. Armadillos along a research site in

the Atchafalaya Basin of Point Coupee Parish were estimated
to have a density of 5 per 7 acres with an antibody
prevalence rate of 16.3%.

In 1952, the only previous

estimate of density for armadillos in another part of
Louisiana was 1 per 7 acres (48),

Future comparisons of

antibody prevalence rates in other groups will also require
new calculations of population density to better understand
the transmission of leprosy.
If environmental factors influence transmission then
armadillos in different environments may have different
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prevalence rates of leprosy. The two groups of Louisiana
armadillos inhabited similar environments. Antibody
prevalence rates of the two groups also were similar.
Environmental conditions of high relative humidity and warm
vegetation temperatures were implicated to influence
increased historical human leprosy prevalence rates in
Norway (80) #

Louisiana armadillos had significantly higher

antibody prevalence rates than Florida armadillos.
Antibodies to Phen-Gl-1 were not detected in Florida
armadillos.

Naturally acquired leprosy has not been

reported in the Florida armadillo. Louisiana and Florida
armadillos appear to be equally susceptible to experimental
infection with M. leprae (93). but, the populations may
occupy different environments and until recently may not
have been in contact. Armadillos in Louisiana slowly
migrated here from Texas and Mexico.

Armadillos may have

been accidentally introduced to Florida in 1925 following
the escape of several pairs from a private zoo in.Cocoa.
Zoologists report that over the years these 2 populations
have eventually merged (48,75,111) f an(j except for leprosy,
there are no discernible differences between the groups.
The actual reason for these observed differences in
antibody prevalence rates between Louisiana and Florida
armadillos is uncertain but m a y be due to differences in
population characteristics,

environment or availability

ofcontact with an infectious source.
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In conclusion,

leprosy is zoonotic in wild armadillos

and these animals may be used to study the transmission of
leprosy.

Serologic screening combined with histology

should provide suitable sensitivity for these
investigations. While for the most part armadillos are
susceptible to leprosy, significant differences in
prevalence rates have been observed. These differences may
be due to environmental factors, population characteristics
or availability of contact with an infectious source.
Future comparisons of leprosy prevalence rates from
armadillos in different environments and/or operating
different population characteristics will help decipher the
transmission of leprosy in armadillos and aid our
understanding of the transmission of leprosy in man.
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Table 5.1
Climatologic Summary 1951 to 19 80
South Central Louisiana*
Month
Jan.
Feb.
Mar.
April
May
June
July
August
Sept.
Oct.
Nov.
Dec.

Relative humidity
am
%
pm
85
54
85

65
59
57
56
57
58
62
62
61
54
58
63

88

90
91
91
92
91
88
88
86

average month
Total

73.79

Rainfall
inches

Rain days

4.58
4.97
4.59
5.59
4.82
3.11
7.07
5.05
4.42
2.63
3.95
4.99

9
9
9
7

51.7
54.2
60.8

8

74.8
80.3
82.1
81.7
78.4
69.1
60.0
54.0

4.22
50.72

Temp
Op

9
13
12

9
5
7
10

8.9
107

68.2

67.9
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Table 5.2
Chi Square Comparison of Phen-Gl-1 Antibody
Prevalence Hates of Louisiana and Florida
Armadillos

Number
Iberville
_________________

Point
Louisiana
Florida
Coupee____________________________

Negative

113

46

163*

Positive

13

9

23

0

Percent
Positive

10.3

16.3

12.5

0

Iberville v. Point Coupee x2=1.31

(not significant)

Louisiana v. Florida

(p<0.05)

x2=4.15

30
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Table 5.3
Legend to figure

Figure 5.1. Scattergram of ELISA absorbances for IgM
antibodies to Phen-Gl-1. Absorbance coded X
1000. Horizontal bars mark equivocal zone
previously determined for the ELISA.
Absorbances above 710 on graph are positive for
IgM antibodies, below 580 negative. Point
Coupee (Louisiana) N=55, Iberville (Louisiana)
N=131, Florida N=30,

(Louisiana N=186).
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Chapter 6 , Abstract:
An enzyme-linked immunosorbent assay (ELISA)

that

detects IgM antibodies to the apparently species specific
phenolic-glycolipid-1 antigen of M. leprae was evaluated
for its efficacy as a management tool in the in vivo
propagation of M. leprae in armadillos.

Screening

armadillos both pre and post experimental infection
indicated that IgM antibodies became detectable on average
after 186 days and remained so over the course of infection.
ELISA absorbances from sera taken at sacrifice showed good
correlation with the liver yield of M. l e p r a e .

An ELISA

absorbance of greater or less than 1 . 2 at sacrifice could
be used to predict satisfaction with the harvest 97% of the
time.

ELISA profiles of resistant armadillos showed that

IgM antibody production was irregular or absent, and the
ELISA could be used to predict resistance in armadillos
both early and late in experimental infections.

The ELISA

successfully identified armadillos with naturally acquired
leprosy and indicated that these armadillos may also have
unusual antibody profiles that would make them unsuitable
for controlled immunologic studies.

IgM antibodies were

detectable earlier and more reliably than previously used
histologic monitoring measures.

The ELISA is less labor

intensive and non-invasive, making it a useful tool in the
management of experimental leprosy infections in
arm a d i l l o s .
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Mycobacterium leprae has not been cultured on
artificial media and investigators must rely on _in vivo
propagation as a source of bacilli.

The nine-banded

armadillo, Dasypus n o v e m cinctus, is well developed as a
host for propagation of M. l e p r a e , and studies have begun
that would use this animal as a model for the pathogenesis
of leprosy (86,93,94,97,194)_

Effective use of animals in

research on infectious diseases requires monitoring of the
host over the course of experimental infection.

Previous

methods to monitor experimental infections of M. leprae in
armadillos have commonly relied on histologic techniques
(97).

These techniques are labor intensive and invasive to

the animal.

Serologic assays are less laborious and offer

hope for greater efficiency in management of experimental
infections,

previous serologic attempts to monitor M.

leprae antibodies in armadillos have relied on traditional
Staphylococcal-A radioimmunoassay methodologies with
iodinated fractions of the sonicated whole leprosy bacillus.
Using undefined antigen mixtures these assays lacked
specificity and only detected M. leprae antibodies
simultaneous with the appearance of a disseminated
infection

(151,160)_

We recently developed an enzyme

linked immunosorbent assay (ELISA)

that detects armadillo

IgM antibodies to the chemically defined and apparently
species-specific phenolic-glycolipid-1
of M. leprae (198).

(Phen-Gl-1)

antigen

w e report here an evaluation of this
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ELISA for applications in the management and investigation
of experimental M. leprae infections in armadillos.

MATERIALS AND METHODS

Serologic and Histologic S a m p l e s ;

Armadillos at

the National Hansen's Disease Center are captured from the
wild and housed for the production of M. l e p r a e .

They are

bled approximately every 90 days, both pre and post
experimental inoculation to examine for the presence of
acid-fast bacilli

(AFB)

in peripheral blood.

Histologic

samples of ear tissues are also taken and examined for AFB
to monitor dissemination of disease.

Plasma from these

bleedings is separated and stored frozen for future
reference.

A total of 457 such plasma samples from 210

different armadillos were used in this study.

Armadillos

were at varying stages of infection with an average
intravenous inoculum of 5 X 10® M. leprae derived from
human leproma and armadillo passage.

Infection status

ranged from not yet inoculated to sacrificed.

Status and

clinical history, according to the date of each serum
sample, were recorded as part of the routine production of
M. l e p r a e .
Antigen:

Native purified phenolic glycolipid-1

(Phen-Gl-1) was prepared by Dr. Patrick Brennan

(Colorado

State University) and obtained through contract with the
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National Institute of Allergy and Infectious Diseases

(Dr.

Darrel Gwinn, Project Officer).
ELISA;

Enzyme-linked immunosorbent assay (ELISA)

was performed according to the method previously
described (198)<
Histology;

Histologic evaluations were performed

using standard methods described previously (215)^

RESULTS

Comparison of ELISA with yield of M. l e p r a e ;
The ELISA absorbancies of sera from 35 armadillos
sacrificed after experimental infection with an average
intravenous inoculum of 5 x 10® M. leprae were compared to
their liver yield of AFB.

Armadillo harvests yielding less

than 1 x 1 0 ? organisms per gram of liver tissue are
considered unsatisfactory for production purposes

(203)_

In this comparison, all armadillos with unsatisfactory
harvests were defined to yield 1 x 1 0 ^ organisms per gram
of liver tissue.
have been less.

Actual yields from these armadillos may
Armadillos yielding greater than 1 X 10?

organisms per gram of liver tissue were compared using the
log of their actual yield.

As shown in Figure 6.1, there

is a significant correlation between ELISA absorbance and
the yield of M. leprae from liver tissues at sacrifice
(r = 0.7261)

(p <0.001).

The majority

(25/26)

armadillos yielding satisfactory harvests

of

(greater than 1 x

100

10 7 M. leprae per gram of liver tissue)

had ELISA

absorbances greater than 1.2 at sacrifice.
armadillos with unsatisfactory harvests
leprae per gram of liver tissue)
greater than 1.2 at sacrifice.

None of the

(1 X 10 7 or less M.

had ELISA absorbances
Using the criteria of ELISA

absorbances greater or less than 1 . 2 the satisfaction with
M. leprae yield at sacrifice was predictable 97%

(34/35) of

the time.
ELISA profile of resistant ar mad ill os :
Serial samples from four armadillos subsequently shown
to be resistant to experimental infection with M. leprae
were screened by the ELISA-IgM v. Phen-Gl-1

(198).

As

shown in Figure 6.2, the resulting ELISA absorbances were
compared with their days post-infection.

Two armadillos

failed to produce detectable IgM antibody to the Phen-Gl-1
antigen in any of the samples tested.

IgM antibody to the

Phen-Gl-1 antigen was detectable in a third armadillo at
246 days post-infection;
days.

but that antibody waned after 452

A fourth armadillo also showed an irregular pattern

of IgM antibody response to the Phen-Gl-1 antigen.

Acid-

fast bacteria were not detected by histologic examination
of ear tissues from these 4 armadillos.
ELISA profile of armadillos with wild-type
i n f ect io n:
Armadillos not experimentally infected with M. leprae
but obtained from the wild with ELISA absorbances greater
than 0.71 are interpretable as positive in the ELISA-IgM v.
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Phen-Gl-1

Presumably these animals have acquired

leprosy naturally in the wild (210),

Retrospective samples

were available for 8 such armadillos in this study (Fig.
6.3).

Their ELISA absorbances before experimental

infection ranged from 0.743 to 1.155.

In one animal (1)

a disseminated acid-fast bacterial infection was found
prior to experimental infection with M. leprae by
histologic examination of ear tissues.
removed from the colony.

This armadillo was

The ELISA absorbances of this

animal increased until the time of removal.

A second

(3)

animal also developed detectable AFB in ear tissues within
26 days of experimental infection with M. l e p r a e .

ELISA

absorbances showed a slight but steady increase until this
animal was also removed from the colony.
armadillos

(2,4,5)

Three other

had a steady and progressive increase in

ELISA absorbances after experimental inoculation with M.
l e pra e.

One (2) developed signs of a disseminated

infection as early as 97 days post inoculation.
other armadillos

The two

(4,5) did not express detectable AFB in

ear tissues over the time these samples were taken.
other armadillos

(6,7,8)

Three

presenting from the wild with .

ELISA absorbances interpretable as positive showed a
different pattern of ELISA absorbances after inoculation
with M. l e p rae .

Absorbances declined such that IgM

anti-Phen-Gl-1 antibodies were not detectable.
Disseminated AFB were detected in ear tissues of one animal
(8 ) at 97 days and it was removed.

ELISA absorbances of
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the other 2 animals

(6,7) eventually increased again to

detectable levels, and in one (7) AFB were detected in the
blood at 404 days.
Kinetics of antibody de v e l o p m e n t ;
A total of 404 serum samples from 19 8 armadillos at
various stages of infection were tested by ELISA to
determine the time course of development of IgM antibodies
to the Phen-Gl-1 antigen.

Armadillos presenting from the

wild with postive ELISA were not included.

Sera from

sacrificed armadillos with unsatisfactory yields were also
not included.

The actual wild experience, as well as the

eventual possibility of resistance for all armadillos,
could not be determined; and some wild infected and
resistant armadillos are no doubt included in this group of
198.

The mean ELISA absorbances were calculated as a mean

of each group of sera taken in 82 day intervals post
infection. Means were plotted according to the last day in
that interval

(Fig. 6.4).

Using the statistical

definitions previously derived for interpreting positive
and negative in this ELISA (198), the average day an
armadillo might be expected to elicit detectable IgM
antibodies to the phenolic-glycolipid - 1 was approximately
200 days post experimental infection.

After rising to

detectable levels, IgM production appears to continue over
the course of infection.

Average times for antibody

detection were also estimated mathematically in a
Litchfield-Wilcoxon test ( H 2 )

(Table 6.1).

This method
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estimated that 50% of the armadillos would have detectable
IgM antibody to Phen-Gl-1 by 186 days post infection with
M. l e p r a e .

The 95% confidence interval on this 50% day

found its boundaries at 150 and 230 days post infection.
At 76 days post infection 16% of the animals probably have
detectable antibody and at 455 days post infection at least
84% of the armadillos should be positive by the ELISA.

In

comparison, the average (arithmetic mean) day armadillos
might exhibit a disseminated acid-fast bacterial infection
as detectable by histologic examination of ear tissues was
found to be 519 days post infection.

The confidence

interval on this average histologic positive day exceeded
the boundaries of the plot.

Additionally, data from 70

armadillos was sufficient to allow comparison of the ELISA
with histologic methods for early identification of
positive animals.

Using those same 82 day intervals, a

positive ELISA preceded a positive histologic examination
by at least 82 days 92% (65/70) of the time.
histology tied 4%

ELISA and

(3/70) of the time, and histology was

positive before ELISA 2.8% (2/70)

of the time.

DISCUSSION

The nine-banded armadillo, Dasypus n ove mcinctus, is
well developed as a host for the in vivo propagation of
M. leprae (94,97)p

Following experimental infection, the

armadillo liver commonly yields 10^ harvestable M. leprae
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per gram of tissue.

Unfortunately, not all armadillos

succumb to a lepromatous infection and approximately 1 0 % of
the animals are resistant to M. leprae

(95,96,172)

Early

identification of resistant armadillos would allow their
removal from production and aid in identifying animals with
unsuitable immunologic characteristics for other studies.
These data indicate that the ELISA-IgM v. Phen-Gl-1 is an
effective method for monitoring armadillos experimentally
infected with M. l e p r a e .

Serologic monitoring is less

labor intensive and may be used effectively earlier in the
course of experimental infection by M. leprae than
histologic methods previously applied.
Histologic examination of ear clip tissues and
microscopic examination of buffy coat blood smears for
acid-fast bacilli are the only previous objective methods
to monitor experimental infections of M. leprae in
armadillos

(97,215)^

Histologic methods are more laborious

than serologic methods and require greater skill and
training.

When acid-fast bacilli are detected by

histologic methods,
infection.

they indicate a disseminated M. leprae

Unfortunately, not all armadillos that succumb

to M. leprae evidence a disseminated infection in ear
tissues or blood smears.

However, apparently all

armadillos that succumb to M. leprae produce detectable IgM
antibodies to the Phen-Gl-1 antigen and 9 6 % (28/29)
ELISA absorbances greater than 1.20.

have

The average time for

histologic methods to indicate a successful disseminated
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infection was 519 days.

The average time for the ELISA to

detect antibodies was 186 days post-infection.

The ELISA

preceded or tied a positive histologic finding by at least
82 days 97% (68/70) of the time.

Therefore,

in the course

of an experimental infection with M. l e p r a e , ELISA
monitoring for IgM antibodies to the Phen-Gl-1 antigen
appears to be more predictive,

less labor intensive,

and an

earlier objective monitoring method than currently used
histologic means.
Resistance to leprosy is governed by cell mediated
immunity (86,94)#

Limited'observations of resistant

armadillos suggest their IgM antibody production to
Phen-Gl-1 is irregular or absent.

In successful infections

this antibody production appears to be continuous and
results in high ELISA absorbances at sacrifice.

After 455

days, at least 84% of all armadillos should develop
detectable IgM antibodies to the Phen-Gl-1 antigen.
Therefore, monitoring armadillos by ELISA may prove useful
in predicting resistance to M. leprae early in the course
of experimental infections in armadillos.
Armadillos are known to harbor a naturally acquired
mycobacterial infection that is indistinguishable from M.
leprae (14,184,185,210,211)#

p or the armadillo to be used

effectively as an animal model in leprosy research or in
the in^ vivo propagation of M. l ep ra e, care must be taken to
avoid animals experienced with leprosy in the wild.
Armadillos presenting from the wild with detectable
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antibodies to Phen-Gl-1 often responded differently from
other animals to experimental infection.

Early

dissemination and progressive rise in antibodies suggests
exacerbation of pre-existing infections.

A drop in

antibody may reflect an unusual immune potential.
Therefore, pre-screening armadillos by ELISA might be
helpful in avoiding wild-type contamination of culture
strains and aid researchers in selecting animals
appropriate for study.
The ELISA-IgM v. Phen-Gl-1 appears to have good
application as an aid in the management of experimental
infections with M. leprae in armadillos.

The assay can

assist in identifying satisfactory harvest times, resistant
animals, and those that experienced leprosy in the wild.
Like humans armadillos appear to be somewhat heterogenous
in their immunologic responses to M. l e p r a e , but on average
appear to develop detectable IgM antibodies to the
Phen-Gl-1 antigen approximately 6 months after experimental
intravenous inoculum of 5 x 10 8 organisms.

This lag in IgM

antibody response is a curious event and may relate to the
size of inoculum or the lipid nature of this antigen.
Future studies with this antigen will better refine this
ELISA as an aid for the in vivo propagation of M. leprae
and may lead to a better understanding of the immune
response in leprosy.
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Table 6.1

LITCHFIELD-WILCOXON

To determine mean time of IgM antibody positive

Days

82

positive/negative

3/14

percent positive.

21

%

164

18 / 51

35 %

246

19 / 34

55 %

328

20 / 26

76 %

365

11 / 12

91 %

492

11 / 15

73 %

614

2 / 2

100

%

696

8 / 9

88

%

Table value = 12.952

Chi squared = 7.83

Data are not heterogenous---- — Curve is a qood fit
*PD ]_6 = 76 days

P D 04 = 455 days

PD 50 = 186 days
(95% confidence interval for PD50 154 to 230 days)
*PD=positive day
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Table 6.2
Legends to figures

Figure 6 .

Yield of M. leprae from armadillo livers is
compared with ELISA absorbance for IgM
antibodies to the Phen-Gl-1 antigen in
sacrifice sera. Armadillos yielding 10 7
51* leptae or less per gram of liver tissue are
considered to yield 1 0 7 bacilli.

Figure 6 .

ELISA absorbances o f ’serial samples from
resistant armadillos are related to their
elapsed time from inoculation. Detectable
antibody ELISA absorbance determined
previously must exceed 710 on graph. Resistant
armadillos do not appear to produce detectable
IgM antibody to Phen-Gl-1 or production is
irregular.

Figure 6 .

ELISA absorbances of serial samples from
armadillos presenting from the wild with
detectable antibodies to Phen-Gl-1 are
compared to their histologic status before
and after experimental infection with
51* l e p r a e * Horizontal dotted lines contain
equivocal zone for interpretation of ELISA
results and were derived previously.
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Absorbances below the lines indicate no
significant antibody, those above the line
indicate antibody present.

Figure 6.4

Mean ELISA absorbances for IgM antibodies to
Phen-Gl-1 of 404 armadillo plasma samples are
compared over 82 day intervals. Mean
absorbance of each interval is plotted at the
end of that interval or the last occurring day
in the interval and bracketed by the SEM.
Horizontal dotted lines (■•■) demark equivocal
zone.

Absorbances above this zone are

considered positive and those below negative.
Vertical stipple line (----) marks 50%
positive day estimated by Litchfield-Wilcoxon
and vertical dotted lines mark 95% confidence
interval on the 50% day. Astericks

(**) bound

the 16% and 84% positive day by the same
method.

Vertical broken line (--- ) marks

arithmetic mean day for detection of acid-fast
bacteria in ear tissues by histologic methods.
Figure demonstrates IgM antibodies become
detectable in armadillos 186 days after
experimental infection and continue to be
detectable thereafter.
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Chapter 7, Abstract:
Enzyme-linked immunosorbent assays

(ELISA) have been

developed to detect antibodies to the phenolic-glycolipid - 1
(Phen-Gl-1) antigen of M. leprae.

Statistical definitions

for positive/negative interpretations in ELISA were derived
by testing sera from 226 leprosy patients,

100 National

Hansen's Disease Center (NHDC) staff members and 108 Pima
Indians.

Leprosy has not been diagnosed in the native

American Indian and Pimas reside in a section of the United
States where contact with leprosy would be rare.

False

positive reactions were not found in sera from Pima Indians.
Therefore, Pimas probably represent "true negatives" for
leprosy serology.

IgM, IgA, and IgG antibodies to

Phen-Gl-1 were detected in 46-62% of the leprosy patients
tested.

These antibodies were also detected in 12-14% of

presumed healthy NHDC staff members.

The predictive value

of antibodies to Phen-Gl-1 is unknown.

No significant

correlation between ELISA absorbances and the bacterial
index of lepromatous patients were found.
correlation did not exceed 0.08.

Coefficients of

It is presumed that

Phen-Gl-1 may persist in tissues to promote a humoral
response even in absence of detectable bacilli.
Anti-microbial therapy with dapsone had no significant
effect on the serologic profiles of lepromatous patients
with respect to serum IgM, IgA, IgG, C3 and specific IgM,
IgA, IgG antibodies to the Phen-Gl-1 antigen.
suffering erythema nodosum leprosm ( E N D

Patients

had no discernable
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trends in antibodies to Phen-Gl-1.

ENL was noted in

patients both with and without detectable antibodies to
Phen-Gl-1. Serological monitoring of patients to predict
ENL does not seem feasible.

The drug thalidomide had

significant effect on levels of total serum IgM and
specific IgM antibodies to Phen-Gl-1.

Levels of other

serum constituents or specific antibodies to Phen-Gl-1 were
not significantly affected.

Further studies on the

persisting nature of this antigen and its possibility to
stimulate a chronic antibody response may yield insight
into the character of immune regulation in leprosy.
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Descriptions of antibody responses to M. leprae have
always been complicated by a lack of specificity in antigen
systems

(61,100)#

^he bacilli bear a number of antigens on

their cell surface which cross-react with other
mycobacterial s p e c i e s ^(94,136)^
glycolipid-1

Recently the phenolic-

(Phen-Gl-1) antigen has been isolated from the

tissues of armadillos experimentally infected with M.
le p r a e .

This antigen is chemically defined and apparently

species specific for M. leprae (22,33,78)#

<phe specificity

of this antigen makes it useful for sero-epidemiologic
studies

(24) an(j provides a unique opportunity to observe

M. leprae specific immune responses in the human host.
We present here an evaluation of the antibody
responses to the phenolic-glycolipid-1

(Phen-Gl-1)

antigen

of M. leprae in leprosy patients, health care personnel in
leprosy, and individuals of a leprosy virgin population.

MATERIALS AND METHODS

Serum S a m p l e s ;

a

total of 435 serum samples were

obtained for testing by enzyme-linked immunosorbent assay
(ELISA) for antibodies to the phenolic-glycolipid-1 antigen
of M. leprae - 226 leprosy patients at the National
Hansen's Disease Center (NHDC)

in Carville, Louisiana, 100

presumed healthy NHDC staff members, and 108 Pima Indians
from Phoenix, Arizona.

Leprosy patients were classified

according to the Ridley-Jopling scale (153) an(j presented
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to us as 196 lepromatous

(LL), 6 borderline-lepromatous

(BL), 14 mid-borderline (BB), and 11 tuberculoid
patients.

(TT)

Leprosy patients were sampled either routinely

or purposefully as they presented as new patients or were
reactional.

Relevant patient information collected

included bacterial index; age; sex; reactional status;
concentrations of total serum IgM, IgA, IgG and the C3
protein of complement; treatment at the time of sampling
according to 17 different regimens with 10 different drugs;
as well as ELISA absorbancies for specific IgM, IgA and IgG
antibodies to the phenolic-glycolipid - 1 antigen.
Bacteriological Index was calculated from the mean of 6
skin scrapings according to the method of Ridley (X 5 6 ) ^
Total human serum IgM, IgA, IgG and the C3 protein of
complement were quantitated by radial-immunodiffusion and
reported in international units according to the
recommendations of the manufacturer
Summerville, N J ) .

(Behring Diagnostics,

Drugs were used in standard therapeutic

doses and considered here only as "in use" or not.
Sera from 100 NHDC staff members were taken routinely
as part of yearly physical examinations.

Samples were

collected from individuals with no overt signs of leprosy
and without regard for race, age, sex, or duties at the
NHDC.

Identifiers were removed from the samples by

clinical laboratory staff and provided as left over
diagnostic specimens.
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Sera from Pima Indians were collected by Dr. William
Knowler, Chief, National Institutes of Health Field
Investigations Unit, Phoenix, Arizona, and made available
for this study.

Sera had been taken as part of a program

for diabetes screening and were stored frozen until use.
The 108 samples represented Pima Indians of mixed age and
sex, who had no overt signs of leprosy and were not
undergoing immunosuppressive therapy.
An t i g e n s
(Phen-Gl-1)

Native purified phenolic-glycolipid-1

was prepared by Dr. Patrick Brennan

(Colorado

State University) and obtained through contract with the
National Institute of Allergy and Infectious Diseases

(Dr.

Darrel Gwinn, Project Officer).
ELISA;

Enzyme-linked immunosorbent assay (ELISA)

was performed by a modification of the method previously
described (198).

Specifically, native purified phenolic-

glycolipid-1 was mixed with 0.05 M carbonate buffer pH 9.2
and suspended via sonication with a 3 m m probe at 70 watts
for 3 minutes

(Ultrasonics, Inc., Plainville, NY).

The

suspended antigen was diluted in the same buffer to a
concentration of 2 jag in 50 jul, the volume which was added
to 48 wells of a 96 well polyvinyl flatbottom microtiter
plate (Cook Labs, Alexandria, V A ) .

The remaining 48 wells

received 50 jil of the carbonate buffer without antigen.
Th e plates were sealed with self-sticking cellophane tape
and incubated overnight at 4°C.

After incubation,

the

wells were washed 3 times for 7 minutes each wash with 200
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jjI of wash buffer consisting of 0.067 M phosphate buffered
saline (PBS) pH 7.2 containing 1% bovine serum albumin
(BSA)

(Fraction V, Sigma, St. Louis, MO).

After washing,

the wells were blocked by the addition of 100 jil of 0 .067 M
PBS pH 7.2 containing 5% BSA and incubated at 37°C for 1
hour in a water bath.

The wells were then washed as before

and 50 ;ul of each serum sample optimally diluted in wash
buffer was added to quadruplicate wells of the microtiter
plate:

2 with antigen and 2 not containing antigen.

The

plates were again sealed and incubated at 3 7 °C for 45
minutes when they were removed and washed as before.
Horseradish peroxidase conjugated IgG fraction of goat
anti-human IgM (mu chain specific), anti-human serum IgA
(alpha chain specific), anti-human IgG
specific)

(gamma chain

(Cappel Laboratories, Cochranville, PA) as

appropriate and optimally diluted and wash buffer was added
to each well in 50 jjI volumes.

The plates w e r e again

sealed and incubated for 45 minutes at 3 7 °C in a water bath
when they were removed and washed as before.
washing,

After

50 p.1 of a solution containing 0.4 mg/ml ortho-

phenylene-diamine (Sigma, St. Louis, MO) with 0.002% H 2 O 2
in 0.1 M sodium acetate buffer pH 5.5 was added to each
well.

The plates we r e incubated at room temperature for 15

minutes when the reaction was stopped with the addition of
50 ^ 1

9 N HCl.

The plates were read for absorbance at 492

nm on a Titertek Multiscan photometer
VA).

(Flow Labs, Richmond,

Mean absorbancies and coefficient of variation (CV)
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for each set (pair) of like wells were calculated.

If the

coefficient of variation exceeded 2 1 %, values were not
taken and tests were repeated.

Mean absorptions from 8

wells receiving only conjugate and antigen were calculated
and subtracted from the mean absorptions of paired antigen
coated wells receiving test

serum and conjugate.

Likewise,

the mean absorptions from 8

wells not coated with

antigen

and receiving only conjugate were subtracted from the mean
absorptions of paired wells
and containing antigen.

receiving test serum,

Finally,

conjugate

the resulting absorbances

from test wells without antigen were subtracted from those
of test wells with antigen.

A quadruplicate series of 8

two-fold dilutions for a high positive lepromatous serum
was included in each test run to allow for correction from
run to run by the method of least squares.

Each serum was

tested in at least 2 replicates and their average was used
for analysis.
Optimal dilutions for the ELISA were determined as
follows:

The optimal dilution for enzyme-antibody

conjugates used in these ELISA assays was defined to be
that dilution of conjugate resulting in the best correlated
linear slope of absorbancies when reacted with serial
dilutions between 0 . 1 ng and 10 ng of chromatographically
purified human IgM, IgA or IgG as appropriate.

For

conjugate lots used in this study those effective optimal
dilutions were anti-human IgM 1:3200, anti-human IgA
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1:12,000, and anti-human IgG 1:24,000.

The optimal

dilution of test serum was found by checkerboard
titration

(79).

Serial dilutions of a battery of high

positive and negative sera were reacted in microtiter wells
containing 2 jug Phen-Gl-1 per well and detected by the
optimally diluted conjugate.

Optimal dilution for the

serum was judged to be that dilution which resulted in the
greatest difference in absorbancies between the positive
and negative sera.

In all cases for use in this study,

that dilution was found to be 1:35 in the tube.
Statistical A n a l y s i s :

Analysis of data were

performed on an IBM 5320 using standard statistical
programs in the Statistical Analysis Systems
commercial program package

(SAS)

(36,192)#

RESULTS

ELISA-IqM;
Reactions:

Evaluation of Positive and Negative

Sera from 226 leprosy patients, 100 National

Hansen's Disease Center (NHDC) staff members,

and 108 Pima

Indians were screened by ELISA for IgM antibodies to the
phenolic-glycolipid-1 antigen.

The resulting absorbancies

w ere pooled and examined in a frequency histogram
(Fig. 7.1).

Inspection of the histogram showed the

population to be positively skewed and a Pearson's
coefficient of skewness was calculated to be +1.4.
Non-specific reaction in ELISA would be expected to occur
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randomly over a normal distribution.

Reactions of specific

antibodies with the phenolic-glycolipid-1 antigen in ELISA
would not be random and they would be expected to deviate
from normal.

The positive skew of the sample population

indicated that the ELISA detected specific antibodies to
the Phen-Gl-1 antigen.
To determine if the ELISA described differences
between the patient, staff, and Pima groups, their
respective absorbances were examined in a scattergram (Fig.
1.2).

Inspection of the scattergram suggested that the

groups were different.

Analysis of variance confirmed that

patients were significantly different (p < 0 .0 0 1 ) from
staff and pimas while staff and Pimas were also
significantly different

(p < 0.05).

A test for extreme

values revealed significant outliers in the staff group but
did not detect outliers in the Pima group.

Distributions

of the individual groups were also examined.

Patients and

staff were both positively skewed with a Pearson's
coefficient of skewness:

1.1 patient and 1.4 staff.

The

Pima group was more normally distributed having a Pearson's
coefficient of skewness of only 0.18.
The approximately normal distribution of ELISA
absorbancies from the Pima group suggested random,
non-specific detection of IgM antibodies.

The positively

skewed distribution of patients and staff probably
reflected reaction of specific IgM antibodies to the
Phen-Gl-1 antigen.

Thus, a 99% confidence interval around
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the distribution of the Pima absorbancies describes the
interval of non-specific detection in the ELISA-IgM, and
can be used for positive and negative interpretations.

By

Z-transformation, the upper boundary of this interval was
calculated to be 0.346.

Absorbances below this upper limit

are within the confidence of non-specific reaction and may
be called negative.

Absorbancies greater than this upper

limit exceed the confidence of non-specific reaction and
may be called positive (as they reflect specific reaction
of IgM antibodies to the Phen-Gl-1 antigen).

Using these

definitions, 0% (0/108) Pima Indians were positive for IgM
antibodies to the Phen-Gl-1 antigen.
NHDC staff members and 62%

(142/226)

However, 12% (12/100)
leprosy patients were

positive for IgM antibodies to the Phen-Gl-1 antigen of M.
leprae.
ELISA-IqA;
Reactions;

Evaluation of Positive and Negative

The combined sample population was also

tested by ELISA for IgA antibodies to the Phen-Gl-1 antigen.
As described above, the resulting absorbances were
inspected in a frequency histogram (Fig. 7.3).

Inspection

of the frequency histogram suggested a definite positive
skew and a Pearson's coefficient of skewness was calculated
to be

1.6.

A positive skew suggested that the ELISA

detected specific IgA antibodies to the phenolicglycolipid-1 antigen.

Closer scrutiny of these groups in a

scattergram (Fig.

suggested that they were different.

7.4)

Analysis of variance described that patients were
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significantly different from both staff and Pima's (p <
0.001) while staff and Pimas were likewise significantly
different (p < 0.01).

A test for extreme values found

significant outliers in the patient and staff groups but
did not identify significant outliers in the Pima group.
Additionally,

the distributions of the patient and staff

groups showed positive skew (Pearson’s coefficient of
skewness:

patients 0.99, staff 3.19).

The distribution of

the Pima group was more normal having a Pearson's
coefficient of skewness of only 0.002.

The approximately

normal distribution reflected the detection of only
non-specific antibodies while the positive skew of patients
and staff suggested detection of specific antibodies to the
Phen-Gl-1 antigen.

Therefore, a 99% confidence interval

constructed about the distribution of the Pima group would
describe the interval of non-specific reaction in the ELISA
and the boundaries of this interval could be used for
positive and negative interpretations.
Z-transformation,

Using

the upper boundary of the 99% confidence

interval about the Pima group was found to be 0.274.

All

(108/108) ELISA absorbancies from the Pima group were found
in this interval and the Pimas were interpretable as
negative.

However, 13%

(13/100) NHDC staff member

absorbancies and 46% (106/226) leprosy patient absorbancies
were found outside this interval suggesting specific
reaction and detection of specific IgA antibodies to the
Phen-Gl-1 antigen.
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ELISA IgG:
Reactions;

Evaluation of Positive and Negative

Likewise, IgG antibodies of the combined

sample population presented a positive skew of 1.23 in the
frequency histogram and scattergram (Fig. 7.5 and 7.6).
Analysis of variance indicated there were significant
differences in the sample population and showed patients
were significantly different from both staff and Pimas

(p <

0.001), while again the Pima group was significantly
different from staff

(p < 0.01).

Significant outliers were

not identified in the Pima group but were found in the
patient and staff groups.

The distribution of the Pima

group had a skew of only 0 .0 1 ; but, the staff and patients
were positively skewed with a Pearson's coefficient of 1.22
and 0.827 respectively.

Thus, pimas did not reflect any

disturbance in their distribution caused by specific
reaction of antibodies to the Phen-Gl-1 antigen; while
patients and staff demonstrated a positive skew, probably
as the result of specific reaction of antibodies with the
phenolic-glycolipid-1 antigen.

A 99% confidence interval

about the distribution of the Pima's describes the interval
of non-specific reaction in the ELISA-IgG and the upper
limit of that interval could be used for interpretation of
positive and negative reactions.

Using z-transformation,

that upper limit was found to be 0.362.
definitions,

100%

Using these

(108/108) Pima Indians had ELISA

absorbancies interpretable as negative.
(14/100) NHDC staff members and 47%

However, 14%

(108/226)

leprosy
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patients had ELISA absorbancies interpretable as positive
for IgG antibodies to the Phen-Gl-1 antigen of M. l e pr ae .
Antibodies by Disease Cl ass ification;

The patient

group was sorted according to their respective disease
classification as lepromatous

(LL), borderline-lepromatous

(BL), mid-borderline (BB), and tuberculoid (TT)
borderline-tuberculoid patients were sampled.

(153),

fj0

ELISA

absorbancies for IgM, IgA, and IgG antibodies to the
Phen-Gl-1 antigen resulting from patient sera of these 4
classes are presented in a scattergram (Figs. 7.7, 7.8, 7.9
respect ive ly ).
Lepromatous patients dominated the sample and appeared
to exhibit the highest ELISA absorbancies for antibodies to
the Phen-Gl-1 antigen.

The level of ELISA absorbancies

decreased when the disease classification became
tuberculoid

(TT).

Antibodies of all classes

IgG) were detected in lepromatous
lepromatous

(IgM, IgA, and

(LL), borderline-

(BL), and mid-borderline (BB) patients.

A

single serum sample from a tuberculoid patient had ELISA
absorbancies interpretable as positive for IgG antibodies
to the Phen-Gl-1 antigen.

Neither IgM nor IgA antibodies

were detectable in the sera from tuberculoid (TT) patients.
The patients under study included both active and
inactive cases on various regimens of treatment.

Serum

samples were taken at a single point in time and
longitudinal screening was not sought.
basis,

On a percentage

63% (123/196) of the lepromatous (LL) patients, 100%

( 6/ 6 ) of the borderline-lepromatous

(BL) patients, and 28%

(4/14) of the mid-borderline (BB) patients had detectable
IgM antibodies to the phenolic-glycolipid-1 antigen.
Likewise, IgA antibodies were detected in 47%
the lepromatous

(LL) patients,

borderline-lepromatous

66%

(92/196) of

(4/6) of the

(BL) patients, and 14% (2/14) of the

mid-borderline (BB) patients; while IgG antibodies were
detected in 48%
50%

(3/6)

(9 3/196) of the lepromatous

of the borderline-lepromatous

(LL) patients,

(BL) patients,

29%

(4/14) of the mid-borderline (BB) patients, and 9% (1/11)
of the tuberculoid (TT) patients.
isotype was detected in 32%

More than 1 antibody

(72/226) of the patient sera,

and all 3 antibody isotypes were detected in 18%

(40/226)

of the patient sera tested.
There were no significant trends with regard to
detection of antibody isotypes in combination.
antibody was detected more frequently,

While IgM

it could equally

well be found independently or in combination with IgA or
IgG.

Likewise, IgA and IgG showed no significant trend

with regard to detection in combination.
Correlation of ELISA with Bacterial Index ( B I ) ;
ELISA absorbancies of IgM, IgA and IgG antibodies to the
Phen-Gl-1 antigen and the bacterial index (BI) were
compared by regression.

Previous comparisons had shown

that serologic profiles of patients treated only with
dapsone or rifampin or on combined therapy of dapsone and
rifampin were not significantly different.

For comparison

of ELISA absorbances according to BI only polar lepromatous
patients treated with dapsone or dapsone in combination
with rifampin, were compared (Figs. 7.10, 7.11, 7.12).

No

significant correlations between ELISA absorbancies and BI
was found.
0.08.

Correlation coefficients (r) did not exceed

Slopes of the regression lines for ELISA

absorbancies of IgM, IgA and IgG antibodies to the
phenolic-glycolipid-1 antigen with respect to BI were not
significant.
negative.

The slope of the IgG regression line was

The 95% confidence intervals about the

regression lines were wide and disparate.

The 95%

confidence interval for ELISA-IgM absorbancies with respect
to BI exceeded the boundaries of the plot.
Levels of Phen-Gl-1 Antibodies with T r e a t m e n t :
ELISA absorbancies for specific antibodies to the Phen-Gl-1
antigen were compared for lepromatous patients undergoing
different therapeutic regimens.

Concentrations of total

serum IgM, IgA, IgG and the C3 protein of complement were
also compared.

Concentrations of total serum

immunoglobulins and C3 were not available for all patients.
Sample sizes of the groups were also different and the
varying degrees of freedom (df) are recorded in the
appropriate tables.

Significant differences between the

groups were described by analysis of variance and a
Bonferroni

(Dunn) t-test.

Statistical comparisons using

these methods are quite conservative and the Bonferroni

131

t-test controls the type I experimental error but generally
has the higher type II error rate than Tukey's

(36,192)#

The selected groups were evaluated for differences
between treatment,

sex, and treatment-sex interactions.

Significant differences influenced by sex were not observed
in ELISA absorbancies for antibodies to the phenolicglycolipid - 1 antigen, nor in concentrations of total
immunoglobulins.

Significant differences influenced by sex

were observed in C3 concentrations.

When sex had a

significant influence on C3 but treatment did not, those
differences were reported here as not significant.

No

significant differences in C3 concentrations are observed
in the treatments examined.
Patients untreated for active leprosy and patients on
dapsone anti-microbial therapy for leprosy are compared in
Table 7.1.

No significant differences were observed

between dapsone treated patients and untreated patients.
Patients continuing on dapsone therapy but undergoing
a reactional episode of erythema nodosum leprosum (ENL) are
compared to non-reactional dapsone treated patients in
Table 7.2.

Total serum IgM antibodies were significantly

higher in the reactional patient.

Total serum IgA, IgG, C3

and specific antibodies to the Phen-Gl-1 antigen were not
observed to be significantly different in the dapsone
treated patient and reactional patient on the same therapy.
Patients with ENL had E L I S A - I g M , IgA, and IgG absorbancies
ranging from positive to undetectable in the ELISA.
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Patients on dapsone therapy and undergoing ENL are
compared to patients on therapy with a combination of
dapsone and thalidomide (the latter as part of treatment
for ENL)

in Table 7.3.

Patients treated with thalidomide

have significantly lower levels of total serum IgM than
patients in ENL and not taking thalidomide.

Total serum

I g A , IgG and C3 were not significantly different.

ELISA

absorbancies for IgM antibodies to the Phen-Gl-1 antigen
were also significantly lower in the thalidomide treated
patient.

Specific IgA and IgG antibodies were not

significantly affected by treatment with thalidomide.
Patients on dapsone therapy but not in ENL were
compared to patients on combined therapy of dapsone and
thalidomide in Table 7.4.

The dapsone-thalidomide treated

patient had significantly lower total serum IgM and
ELISA-IgM for antibodies to the Phen-Gl-1 antigen than
patients on dapsone only.

Concentrations for total serum

IgA, IgG and C3, as well as specific IgA and IgG ELISA
absorbancies, were not shown to be significantly different.

DISCUSSION

Using ELISA, IgM, IgA and IgG antibodies to the
phenolic-glycolipid-1 antigen of M. leprae were detectable
in the sera of leprosy patients.

These antibodies were

also detectable in sera from staff members at the National
Hansen's Disease Center (NHDC), but were not detectable in
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sera from Pima Indians.

Leprosy has not been diagnosed in

the native American Indian and Pima's reside in a section
of the United States where reports of leprosy are extremely
rare (58,68)^

In that manner,

Pima Indians might be

considered as leprosy virgin and sera from this group may
be used as negative controls in leprosy serology.
ELISA yield results in objectively derived numeric
absorbance units that are readily used in statistical
analysis.

Using ELISA absorbancies for sera from Pima

Indians, statistical definitions for interpretation of
positive/negative ELISA results were derived.

Pima Indian

sera were shown to react non-specifically over an
approximately normal distribution in ELISA for antibodies
to the Phen-Gl-1 antigen.

ELISA absorbancies for sera from

leprosy patients and NHDC staff did not result in normal
distributions but showed positive skew.

This skew

reflected reaction of specific antibodies with the
Phen-Gl-1 antigen.

A 99% confidence interval constructed

about the Pima distribution described the range for
non-specific reactions in the ELISA.

The upper boundary of

that interval described the probable upper limit for
non-specific reaction and was used in definition of
positive and negative in ELISA absorbancies.
Using these definitions, antibodies to the Phen-Gl-1
antigen were detected in 12-14% of presumed healthy NHDC
staff members.

Antibody prevalence rates have not

previously been reported for health care delivery personnel
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in leprosy.

Antibodies to the phenolic-glycolipid-1

antigen have been reported in family members and contacts
of leprosy patients

(24,217),

Some NHDC staff members come

in constant contact with leprosy patients and are likely
hyper-exposed to M. leprae in their environment.

Leprosy

personnel have been noted to have higher relative risk
rates for contracting leprosy than other groups (51),
These data indicate that staff members also have a high
probability of developing antibodies to M. l e p r a e .

At this

time, the relative risk, as may be ascribed to persons with
a known environmental exposure to M. leprae and having
positive serological indications, cannot be discerned.

The

predictive value of IgM antibodies to Phen-Gl-1 is a
continuing research interest for sero-epidemiology.
Leprosy patients m ay be classified according to the 5
group scheme of the Ridley-Jopling scale (153),

This

method groups patients according to their own disease
status and recognizes the split anergy of the leprosy
immune response (26,31,101),

Polar lepromatous patients

have a predominant humoral immune response but lack
competent cell mediated immunity to M. l e p r a e .

Patients to

the tuberculoid pole have a predominant cell-mediated
immune response but lack strong humoral immunity to M.
le p r a e .

Patients in this study also seemed to reflect that

dichotomy with regard to IgM, IgA and IgG antibodies to the
Phen-Gl-1 antigen.

These observations are in keeping with

those of previous investigators who noted a decline in IgM
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or total immunoglobulins as patient classification moved
from polar lepromatous
(19,26,133)_

(LL) to polar tuberculoid (TT)

ELISA-IgM absorbancies in lepromatous

patients also were the highest recorded.

IgM was the most

commonly detected isotype in leprosy patients.

These data

are in keeping with assertions by previous investigators
that IgM antibodies to Phen-Gl-1 may be the most
appropriate isotype for sero-epidemiology (24,217)_
However, IgM, IgA and IgG antibodies to the Phen-Gl-1
antigen were also detectable in persons environmentally
exposed to M. leprae and in treated and untreated leprosy
patients.

Though no discernable trends could thus far be

revealed in detecting combinations of antibodies,

isotypes

other than IgM may have relevant roles in sero-epidemiology
and clinical investigations.
To determine if levels of Phen-Gl-1 antibodies in
lepromatous patients might be affected by their status at a
given point in time, selected groups were examined.

Using

extracts of M. l e p r a e , previous investigators have asserted
correlation between the level of antibody activity and the
bacterial load of the lepromatous patient (130,131)e

ELISA

absorbancies for IgM, IgA, and IgG antibodies to the
phenolic-glycolipid - 1 antigen had no significant
correlations with the bacterial index of lepromatous
patients on anti-microbial therapy.

As shown in Figures

7.9, 7.10, and 7.11, even lepromatous patients with a BI of
0 may have detectable antibodies to the Phen-Gl-1 antigen.
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The persistence of detectable antibody in patients with a
BI of 0 probably indicates that this antigen persists after
acid-fast bacilli have been cleared.

Granulomas of

resolving lepromatous patients contain no detectable
bacilli but foamy macrophages may be detected (85).

Foamy

inclusions in these macrophages may be lipid from M. leprae
and could be responsible for the persisting humoral
response.
To determine if serologic profiles of lepromatous
patients were influenced by drug therapy or erythema
nodosum leprosum (ENL), selected groups were examined.
Concentrations of total serum immunoglobulins, the C3
protein of complement as well as ELISA absorbancies for
IgM, IgA and IgG antibodies to the Phen-Gl-1 antigen, were
tested for significant differences.

The groups were

selected to assess 4 phases of the disease in the
lepromatous patient: untreated new patient, antimicrobially treated, reactional, and treated for reaction.
When an untreated leprosy patient first presents,
is started on a course of anti-microbial therapy.

he

Dapsone

is an anti-microbial in common use for the treatment of
leprosy.

In this study, patients on anti-microbial therapy

with dapsone had a similar serologic profile to untreated
patients.

Previous reports have suggested that

anti-microbial therapy over time tends to decrease levels
of IgM antibodies

(131,132,135)#

These reports were based

on longitudinal sampling of individual patients.
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Longitudinal samples were not tested in this study and
individual patients were noted to be highly heterogeneous.
Previous studies have also noted great heterogeneity in
antibody responses from leprosy patients of similar groups
(130,133)^

Therefore, the observations reported here do

not contradict those previous conclusions.
Patients undergoing an episode of erythema nodosum
leprosum (ENL) had significantly elevated levels of total
serum IgM over non-reactional dapsone treated patients.
ENL is thought to be an Arthus type hypersensitivity
reaction possibly mediated by IgM antibodie"
21 2, 214 )^

(29,87,178,

previous investigators have noted elevated serum

IgM during the reactional episode and hypothesized that
their reaction with M. leprae antigens might initiate
ENL (30,170,178)^

jf ^he phen-Gl-1 antigen is involved in

ENL then one mi gh t expect changes in ELISA absorbances of
ENL patients depending on whether: a) there was new
production of antibody? or b) there was excess consumption
of antibody.

No changes in ELISA absorbances would be

expected if: c) there is a relative balance between
production and consumption of Phen-Gl-1 antibodies in ENL;
or d) antibodies to Phen-Gl-1 are not involved in ENL.

In

the present study, ELISA absorbances for specific
antibodies to Phen-Gl-1 were not significantly different in
reactional patients.

Some patients in ENL did not have

detectable antibody to Phen-Gl-1.

No trends were revealed

in detecting antibody that might make serological
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monitoring useful in predicting ENL.

Therefore, these data

provide no evidence that Phen-Gl-1 is directly involved in
the pathogenesis of ENL.
On the other hand, patients treated with thalidomide
had significantly depressed ELISA-IgM absorbancies for
antibodies to the Phen-Gl-1 antigen.
IgM were also significantly lower.

Levels of total serum
Thalidomide has been

shown to polyclonally suppress de novo IgM production to
T-dependent antigens but not to T-independent antigens
(175,176) #

>rhe suppression seen here in total serum IgM

and specific IgM antibodies m a y be the result of polyclonal
suppression or could indicate that IgM antibodies to the
phenolic-glycolipid-1 antigen are consumed during ENL.

If

consumed, their production is inhibited by the action of
thalidomide.

Therefore suppression of IgM antibodies to

the Phen-Gl-1 antigen by the action of thalidomide suggests
that phen-Gl-1 is a T-dependent antigen of M.

leprae.

This

is in keeping with the appearance of IgM antibody to
Phen-Gl-1 in M. leprae infected athymic nude mice only
after reconstitution with spleen cells form syngeneic
donors

(unpublished observations).

In summary,

statistical definitions have been

developed for the interpretation of positive and negative
reactions in ELISA for IgM, IgA, and IgG antibodies to the
phenolic-glycolipid-1 antigen of M. l e p r a e .
definitions,

Using these

IgM, IgA, and IgG antibodies were detectable

in the sera of leprosy patients, and more commonly
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detectable in those not classified as tuberculoid.

These

antibodies were also detectable in presumably healthy
individuals at least some of whom are environmentally
exposed to M. l epr ae .

The predictive value of detecting

these antibodies in persons environmentally exposed to M.
leprae cannot be ascertained.

False positive reactions for

antibodies to the Phen-Gl-1 antigen were not found in a
group of native American Pima Indians.
mycobacterial infections,

While not immune to

leprosy has never been diagnosed

in the native American Indian and Pimas reside in a region
of the United States where contact with M. leprae would be
rare.

Therefore, Pimas probably represent "true negatives"

for leprosy serology.

There appear to be no significant

correlations between ELISA absorbancies for antibodies to
the Phen-Gl-1 antigen and the bacterial index of the
lepromatous patient.

It is presumed that this lipid

antigen may persist in tissues to promote a humoral
response even in the absence of detectable acid-fast
bacilli.

Anti-microbial therapy with dapsone had no-

detectable effect on the serologic profiles of lepromatous
patients.

Antibodies to the phenolic-glycolipid-1 antigen

could not be implicated directly in the pathogenesis of ENL.
There were no discernible trends in ELISA absorbancies for
antibodies to this antigen in patients suffering ENL and
prospective monitoring of patients by ELISA in hopes of
predicting ENL does not seem feasible.

The drug

thalidomide had significant effect on IgM antibodies to
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this antigen and Phen-Gl-1 may be a T-dependent antigen of
M. l e pr ae.

Further studies on the persisting nature of

this antigen and its ability to stimulate a chronic
T-dependent response m a y yield interesting insight into the
character of immune regulation in leprosy.
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Table 7.1
Serologic profile of untreated
lepromatous patients and lepromatous patients
treated with dapsone

DAPSONE

UNTREATED
X

S

df

P

83

198

112

24

NS

263

102

242

131

24

NS

IgG

188

35

186

56

24

NS

C3

10 6

23

101

12

24

NS

ELISA#
IgM

765

464

751

436

36

NS

IgA

329

293

530

386

36

NS

IgG

430

267

537

385

36

NS

X
Serum*
IgM

197

IgA

S

x=mean; s=standard deviation; df=degrees freedom;
£=probability by t-test; NS=not significant
levels are expressed for total serum concentration in
IU/dl
#ELISA absorbances for specific antibodies to Phen-Gl-1
antigen.
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Table 7.2. Serologic profile of lepromatous patients
treated with dapsone but not in reaction
and those treated with dapsone but undergoing
erythema nodosum leprosum.

DAPSONE

REACTIONAL
X

S

df

P

83

264

225

23

0.05

263

10 2

273

147

23

NS

IgG

188

35

19 6

135

23

NS

C3

106

23

99

13

23

NS

ELISA#
igM

765

464

949

342

33

NS

IgA

329

29 3

561

413

33

NS

IgG

430

267

361

221

33

NS

X
Serum*
IgM

197

IgA

S

x=mean; s=standard deviation; df=degrees freedom;
p=probability by t-test; NS=not significant
levels are expressed for total serum concentration in
IU/dl
$ELISA absorbances for specific antibodies to Phen-Gl-1
antigen.
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Table 7.3. Serologic profile of lepromatous patients
on dapsone and those on combination therapy
of dapsone with thalidomide.

DAPSONE
X

S

THALIDOMIDE
S

df

P

151

62

28

0.05

10 2

197

101

28

NS

188

35

169

55

28

NS

C3

10 6

23

100

12

28

NS

ELISA#
IgM

765

464

377

328

39

0.05

IgA

329

29 3

224

19 2

39

NS

IgG

430

267

523

235

39

■ NS

Serum*
IgM

19 7

83

IgA

263

IgG

X

x=mean; s=standard deviation; df=degrees freedom;
p=probability by t-test; NS=not significant
levels are expressed for total serum concentration in
IU/dl
“ELISA absorbances for specific antibodies to Phen-Gl-1
antigen.
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Table 7.4. Serologic profile of lepromatous patients
on dapsone in reaction with erythema nodosum leprosum
and patients on combination therapy
of dapsone with thalidomide

REACTIONAL

THALIDOMIDE

X

S

X

Serum*
IgM

S

df

P

264

225

151

62

13

0.05

IgA

27 3

147

197

101

13

NS

IgG

19 6

135

169

55

13

NS

99

13

1 00

12

13

NS

ELISA#
IgM

949

342

377

328

18

0.05

IgA

561

413

224

19 2

18

NS

IgG

361

221

523

235

18

NS

C3

x=mean; s-standard deviation; df=degrees freedom;
p=probability by t-test; NS=not significant
levels are expressed for total serum concentration in
#ELISA absorbances for specific antibodies to Phen-Gl-1
antigen.
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Table 7.5
Legends to figures.

Figure 7.1

Frequency histogram of ELISA absorbances for
IgM antibodies to Phen-Gl-1 from 226 leprosy
patients,

100 NHDC staff, and 108 Pima Indians.

Absorbance is X 1000 and plot is over 30 equal
class intervals of 50 absorbance units each.

Figure 7.2

Scattergram of ELISA absorbances for IgM
antibodies to Phen-Gl-1 sorted according to
group. Absorbance is coded X 1000. Bars mark
the mean of each group. Brackets were found by
Z-transformation and indicate the upper 99%
confidence limit of each distribution.
Horizontal line at 346 demarks limit for
non-specific ELISA absorbances as described by
Pima distribution.

Figure 7.3

Frequency histogram of ELISA absorbances for
IgA antibodies to Phen-Gl-1 from 226 leprosy
patients, 100 NHDC staff, and 108 Pima Indians.
Absorbance is X 1000 and plot is over 30 equal
class intervals of 50 absorbance units each.

Figure 7.4

Scattergram of ELISA absorbances for IgA
antibodies to Phen-Gl-1 sorted according to
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group. Absorbance is coded X 1000. Bars mark
the mean of each group. Brackets were found by
Z-transformation and indicate the upper 99%
confidence limit of each distribution.
Horizontal line at 274 demarks limit for
non-specific ELISA absorbances as described by
Pima distribution.

Figure 7.5

Frequency histogram of ELISA absorbances for
IgG antibodies to Phen-Gl-1 from 226 leprosy
patients, 100 NHDC staff, and 108 Pima Indians.
Absorbance is X 1000 and plot is over 30 equal
class intervals of 50 absorbance units each.

Figure 7.6

Scattergram of ELISA absorbances for IgG
antibodies to Phen-Gl-1 sorted according to
group. Absorbance is coded X 1000. Bars mark
the mean of each group. Brackets were found by
Z-transformation and indicate the upper 99%
confidence limit of each distribution.
Horizontal line at 363 demarks limit for
non-specific ELISA absorbances as described by
Pima distribution.

Figure 7.7

Scattergram of ELISA absorbances for IgM
antibodies to Phen-Gl-1 for 226 leprosy
patients sorted according to classification:
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L L =le pro ma tou s, BL=borderline lepromatous,
BB=mid-borderline, TT=tuberculoid

Figure 7.8

Scattergram of ELISA absorbances for IgA
antibodies to Phen-Gl-1 for 226 leprosy
patients sorted according to classification.
LL=le pro ma tou s, BL=borderline lepromatous,
BB=mid-borderline, TT=buberculoid.

Figure 7.9

Scattergram of ELISA absorbances for IgG
antibodies to Phen-Gl-1 for 226 leprosy
patients sorted according to classification.
L L =le pro ma tou s, BL-borderline lepromatous,
BB=mid-borderline, TT=tuberculoid.

Figure 7.10 Correlation by regression of ELISA absorbances
for IgM antibodies to Phen-Gl-1 and bacterial
index of nonreactional LL patients on therapy
with dapsone or dapsone in

combination with

rifampin. Absorbance is coded

X 1000.

Correlation coefficient=(r). Broken line (--- )
is regressed, not significant.

Confidence

interval of regressed line exceeded the
boundaries of the plot.

Figure 7.11 Correlation by regression of ELISA absorbances
for IgA antibodies to Phen-Gl-1 and
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bacterial index of nonreactional LL patients on
therapy with dapsone or dapsone in combination
with rifampin. Absorbance is coded X 1000.
Correlation coefficient=(r). Broken line (--- )
is regressed, not significant. Solid line is
95% confidence interval of regression line.

Figure 7.12 Correlation by regression of ELISA absorbances
for IgG antibodies to Phen-Gl-1 and bacterial
index of nonreactional LL patients on therapy
with dapsone or dapsone in combination with
rifampin. Absorbance is coded X 1000.
Correlation c o e f f i c i e n t s r ) . Broken line (--- )
is regressed, not significant. Solid line is
95% confidence interval of regression line.
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SUMMARY

In summary,

enzyme-linked immunosorbent assays

(ELISA)

have been developed to detect antibodies to a chemically
defined and apparently species specific phenolicglycolipid-1

(Phen-Gl-1)

antigen of Mycobacterium l ep ra e.

Previous serologic procedures have lacked both sensitivity
and specificity as they relied on undefined antigen
mixtures and were complicated by the plethora of cross
reacting antigenic determinates of mycobacterial species.
The assays have been developed with statistical definitions
for interpretation of positive and negative reactions.
They are developed for application in the two major hosts
of leprosy: man and armadillos.
The immunoglobulin IgM is an evolutionarily primitive
molecule.

Serologic cross reactivities of IgM antibodies

have been noted among a number of species.

Such cross

reactivity was also noted between human and armadillo IgM.
Using commercially prepared enzyme-anti-antibody conjugates
directed against human IgM, armadillo IgM antibodies are
detectable by ELISA.

The ELISA-IgM v. Phen-Gl-1 was

developed for use in armadillos and evaluation showed it to
be highly sensitive and specific.

The assay was optimized

to have a calculatable specificity of 100%.

Such high

specificity is especially useful in sero-epidemiologic
studies.
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Leprosy is zoonotic in the armadillo, Dasypus
novemcinctus.

The origin of these infections has been the

subject of great debate.

Understanding their origin may

have impact on our understanding of the transmission and
distribution of leprosy.

A retrospective serological

survey of armadillos taken in years pre-dating their use in
leprosy,

found antibodies to the phenolic-glycolipid - 1

antigen in 17 of the armadillos examined.

These antibodies

were not absorbable with other mycobacterial species and
presumably were elicited as a result of contact with M.
le pr ae.

Thus,

the disease of armadillos appears to be a

naturally acquired zoonosis.
The transmission of leprosy is not yet understood.
Studies of the disease are complicated by a long incubation
period,

low susceptibility, and high mobility of the human

population.

However,

naturally acquired leprosy is

zoonotic in the armadillo and may be used as an animal
model to study the transmission of leprosy.

Transmission

may be affected by environmental conditions,

population

characteristics or other intricacies in the transmission of
leprosy.

To better develop the armadillo as an animal

model for the transmission of leprosy, prevalence rates
were estimated in armadillos from two parishes in Louisiana.
Modern antibody prevalence rates for Louisiana averaged
12.5%.

variations in prevalence were noted between

Louisiana and Florida where there have been no reports of
zoonotic leprosy.

These variations must be the result of

163

some factors affecting the transmission of the disease.

To

better understand these factors, data base information
concerning the leprosy positive armadillo habitat of
Louisiana has been developed.

Future comparison of

prevalence in armadillos of similar and different habitats
will aid our understanding of factors that influence
transmission of leprosy.
M. leprae have not been cultivated on artificial media
and must be propagated in vivo.

The armadillo (Dasypus

no ve mcinctus) is well developed as a host for M. l e pra e ,
and is evolving as an animal model for the study of leprosy.
Understanding the immunologic responses of armadillos as a
result of experimental infection with leprosy will advance
their use as models and may impact the efficiency of in
vivo propagation.

Testing of armadillos for IgM

antibodies to the phenolic glycolipid - 1 antigen showed that
there is a slow initial IgM response to this antigen
requiring an average of 186 days to become detectable by
the ELISA.

These antibodies appear to persist over the

course of infection and may be detected for up to 1140 days.
Armadillos that succumb to M. leprae infection develop high
antibody levels and ELISA absorbances of greater or less
than 1 . 2 may be used to predict the outcome of an
experimental infection 97% of the time.

Armadillos that do

not succumb to experimental infection appear to have an
irregular or absent IgM antibody response to the phenolicglycolipid-1 antigen.

Antibodies were earlier and more
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reliable indicators of infection than previously used
histologic monitors.

These response profiles may be used

to predict resistance in armadillos both early and late in
the course of experimental infection and will have impact
on the efficiency of in vivo propagation.

Armadillos with

naturally acquired leprosy were also noted to have
irregular response patterns.

Pre-screening of armadillos

to identify animals with a wild infection will aid
researchers in preserving their culture strains of M.
leprae and will allow identification of animals that would
be unsuitable for modeling studies.

Knowledge of the

immunologic responses of armadillos to M. leprae antigens
m ay benefit our understanding of the immune response of
human leprosy patients.
Leprosy has its greatest impact as a severe infection
of man.

The leprosy patient presents with a complex array of

clinical and immunologic symptoms, and management of the
disease is complicated.

To determine if serologic monitoring

may have impact on the diagnosis and management of human
leprosy, ELISA were developed.

Statistical definitions were

developed for the interpretation of positive and negative
reactions in ELISA for IgM, IgA, and IgG antibodies to the
phenolic glycolipid-1 antigen of M. l ep rae .

Using these

definitions, IgM, IgA, and IgG antibodies were detectable in
the sera of leprosy patients, and more commonly detectable in
those not classified as tuberculoid.

These antibodies were

also detectable in presumably healthy individuals who are
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environmentally exposed to M. l e p r a e .

The predictive value

of detecting these antibodies in persons environmentally
exposed to M. leprae cannot be ascertained.

False positive

reactions for antibodies to the phenolic-glycolipid - 1 antigen
were not found in a group of native American Pima Indians.
While not immune to mycobacterial infections, leprosy has
never been diagnosed in the native American Indian and Pimas
reside in a region of the United States where contact with M.
leprae would be rare.
"true negatives"

Therefore, Pimas probably represent

for leprosy serology.

There appear to be no

significant correlations between ELISA absorbancies for
antibodies to the phenolic-glycolipid - 1 antigen and the
bacterial index of the lepromatous patient.

It is presumed

that this lipid antigen may persist in tissues to promote a
humoral response even in the absence of detectable acid-fast
bacilli.

Anti-microbial therapy with dapsone had no

significant effect on the serologic profiles of lepromatous
patients.

Antibodies to the phenolic-glycolipid-1 antigen

could not be implicated directly in the pathogenesis of ENL.
There were no discernible trends in ELISA absorbancies for
antibodies to this antigen in patients suffering ENL and
prospective monitoring of patients by ELISA in hopes of
predicting ENL does not seem feasible.

The drug thalidomide

had significant effect on IgM antibodies to this antigen and
phenolic-glycolipid-1 may be a T-dependent antigen of M.
leprae.

Further studies on the persisting nature of this

antigen and its propensity to stimulate a chronic T-dependent
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response, m ay yield interesting insight into the character of
immune regulation in leprosy.
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